WO2023149766A1 - Cosmetic composition comprising saffron flower extract and danshen extract - Google Patents

Cosmetic composition comprising saffron flower extract and danshen extract Download PDF

Info

Publication number
WO2023149766A1
WO2023149766A1 PCT/KR2023/001653 KR2023001653W WO2023149766A1 WO 2023149766 A1 WO2023149766 A1 WO 2023149766A1 KR 2023001653 W KR2023001653 W KR 2023001653W WO 2023149766 A1 WO2023149766 A1 WO 2023149766A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
extract
saffron
cosmetic composition
saffron flower
Prior art date
Application number
PCT/KR2023/001653
Other languages
French (fr)
Korean (ko)
Inventor
정수경
경서연
김선영
장유진
윤석균
강승현
김영희
김연준
박명삼
Original Assignee
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스 주식회사 filed Critical 코스맥스 주식회사
Publication of WO2023149766A1 publication Critical patent/WO2023149766A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat

Definitions

  • It relates to a cosmetic composition.
  • the skin is largely divided into three layers of tissues, epidermis, dermis, and hypodermis, in order from the outside, and functions to protect the human body from physical and chemical external environmental stimuli.
  • the epidermis is further divided into the stratum corneum, the granular layer, the prickle layer, and the basal layer.
  • the stratum corneum contains about 10 to 20% of water and exists in the outermost part of the human body, suppressing the evaporation of moisture to the outside of the body and excessive substances from the outside. It acts as a barrier to penetration.
  • the surface of the stratum corneum is covered with a thin natural protective film made of sebum from the sebaceous glands and sweat from the sweat glands to prevent evaporation of moisture.
  • One aspect is to provide a cosmetic composition for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
  • Another aspect is to provide a composition for external application for skin for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
  • Another aspect is to provide a health functional food composition for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
  • compositions for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
  • the saffron ( Crocus Sativus ) is a dried spice prepared by extracting the pistil of a flower, and includes compounds such as crocin, picrocrocin, safranal, and crocetin. are doing Among the compounds, crocin is a glycoside mixture that gives saffron a yellow-red color, and the main component of crocin is ⁇ -crocin. Generally, saffron flowers are discarded after removing the stigma. In particular, saffron flowers, like pistils, have a deep red color due to the crocin component, so there is a risk of discoloration, so it is difficult to use them as cosmetic ingredients at high concentrations.
  • saffron flowers specifically saffron petal extract, reduce the expression of MMP-1, which is increased by ultraviolet rays in skin fibroblasts, increase the expression of collagen, and promote cell migration in aged fibroblasts, thereby causing skin wounds. It was confirmed that not only can treat, but also exhibits a skin regeneration effect. Therefore, the saffron flower not only contains various active ingredients effective for improving skin beauty, but also has a lower cost compared to pistils, so it can be used as an alternative raw material.
  • Salvia Miltiorrhiza is a perennial herbaceous plant belonging to the Lamiaceae family, and is similar to ginseng in shape and is known to have a reddish color, promote blood circulation in the human body, and have excellent cholesterol-lowering effects.
  • the saffron flower extract is obtained by extracting saffron flowers with water, C1 to C4 lower alcohol, or a mixture thereof as a solvent, and the saffron flower extract may contain a crocin compound. After cutting the saffron flowers, it may be extracted by adding 2 to 20 times the weight of the saffron flowers with water, alcohol, or a mixture thereof. In addition, the extraction may be performed at 30 ° C to 100 ° C, and may be extracted for 1 to 10 hours.
  • the extraction method may use cold needle extraction, ultrasonic extraction, or reflux cooling extraction method, and the number of extractions may be performed for 1 to 5 times.
  • the saffron flower extract may be obtained by extracting the saffron flower with a mixture of water and a carbonhydrase as a solvent.
  • carbohydrates have a high molecular weight and are insoluble, there is a problem in that they are difficult to absorb into the body.
  • the carbolytic enzyme catalyzes a reaction that converts carbohydrates present in saffron flowers into monosaccharides such as glucose and maltose. Therefore, the saffron flower extract according to one embodiment contains a monosaccharide having a low molecular weight to promote skin absorption of active ingredients of the saffron flower, thereby maximizing the skin condition improvement effect.
  • the saffron flower extract may be obtained by extracting saffron flowers with a mixture of water and a carbonhydrase as a solvent and decolorizing the saffron flowers by chemical, physical, electrical or biological methods.
  • the decolorization may be performed by a filtration method using a filtering agent. Since the crocin compound is removed by the decolorization, there is no risk of discoloration, so it can be used in cosmetics at a high concentration.
  • the composition according to one embodiment may selectively apply a step of decolorizing the crocin compound according to the content of the saffron flower extract.
  • the composition may have skin barrier strengthening, skin wrinkles, skin elasticity or moisturizing effects.
  • skin aging refers to both tangible and intangible changes that appear in the skin with age, such as thinning of the epidermis, number of cells or blood vessels in the dermis, DNA damage repair ability, cell replacement cycle, It refers to reduction in wound healing, skin barrier function, epidermal moisture retention, sweat secretion, sebum secretion, vitamin D production, physical damage defense, chemical substance elimination ability, immune response, sensory function, and thermoregulation.
  • the composition may be used to improve skin aging caused by exogenous factors or endogenous factors.
  • the extrinsic factor refers to various external factors, such as ultraviolet rays (light), and the endogenous factor is also referred to as a chronological factor and refers to a factor mainly caused by the passage of time. That is, the skin aging is not only premature aging symptoms induced by external stimuli such as ultraviolet rays, pollution, cigarette smoke, chemicals, etc., but also a natural aging phenomenon that occurs as the proliferation of skin cells decreases with age. It is a concept that includes wrinkles, loss of elasticity, skin sagging and dryness. In addition, wrinkles include stimulation caused by changes in internal and external factors that cause wrinkles by changing components constituting skin tissue.
  • the aging may be photoaging.
  • photoaging is a phenomenon caused by external environmental factors, and the most representative factor is ultraviolet rays. Ultraviolet rays cause damage to biocomponents such as activation of proteolytic enzymes, chain scission of matrix proteins, and abnormal cross-linking, and repetition of these mechanisms results in apparent skin aging.
  • wrinkle refers to a state in which elasticity of the skin is lost and loosened, and for example, the skin may be folded.
  • prevention or improvement of skin wrinkles may mean any action of preventing or improving wrinkles by suppressing the expression of wrinkle-related factors or increasing the total amount of collagen.
  • the "strengthen the skin barrier” may refer to any action that enhances the function of the skin barrier, which is located at the outermost layer of the skin and prevents loss of moisture and nutrients.
  • Impaired skin barrier function may refer to any changes that occur in the skin due to reduced or damaged skin barrier function. Examples include increased skin wrinkling, dryness, dermatitis, atopic dermatitis, allergic dermatitis, acne, and the like.
  • the "moisturizing skin” may refer to any action that maintains skin moisture or prevents moisture loss.
  • the Danshen extract may be obtained by extracting Danshen with water, C1 to C4 lower alcohol, or a mixture thereof as a solvent. After cutting the Danshen root, it may be extracted by adding 2 to 20 times the weight of the Danshen root with water, alcohol, or a mixture thereof. In addition, the extraction may be performed at 30 ° C to 100 ° C, and may be extracted for 1 to 10 hours.
  • the extraction method may use cold needle extraction, ultrasonic extraction, or reflux cooling extraction method, and the number of extractions may be performed for 1 to 5 times.
  • the saffron flower extract and Danshen root extract may be mixed in a weight ratio of 1:0.01 to 1:10.
  • the saffron flower extract and Danshen root extract are, for example, 1:0.01 to 1:10, 1:0.1 to 1:10, 1:1 to 1:10, 1:5 to 1:10, 1:5 to 1 :8 or 1:7 to 1:9.
  • the mixing ratio of the saffron flower extract and the Danshen root extract is less than the above range, there is a problem in that the synergistic effect of improving skin condition by the saffron flower extract and the Danshen root extract is not sufficiently exhibited.
  • the composition is 0.001% to 80% by weight, for example, 0.01% to 60% by weight, 0.01% to 40% by weight, 0.01% to 30% by weight, based on the total weight of the composition, 0.01% to 20% by weight, 0.01% to 10% by weight, 0.01% to 5% by weight, 0.05% to 60% by weight, 0.05% to 40% by weight, 0.05% to 30% by weight, 0.05% by weight % to 20% by weight, 0.05% to 10% by weight, 0.05% to 5% by weight, 0.1% to 60% by weight, 0.1% to 40% by weight, 0.1% to 30% by weight, 0.1% to 0.1% by weight 20% by weight, 0.1% to 10% by weight, or 0.1% to 5% by weight of a mixture of saffron flower extract and Danshen root extract.
  • the composition according to one aspect may have a synergistic activity of improving skin beauty and wound healing by the mixture of the saffron flower extract and the Danshen root extract.
  • the composition may be a cosmetic composition.
  • the cosmetic composition may have, for example, softening lotion, nutrient lotion, massage cream, nutrient cream, essence, pack, gel, ampoule, or skin-adhesive cosmetic formulation.
  • ingredients included in the cosmetic composition may include ingredients commonly used in cosmetic compositions other than the composition as active ingredients, for example, conventional adjuvants and carriers such as stabilizers, solubilizers, vitamins, pigments and flavors. can include
  • composition may be a composition for external application for skin.
  • the external skin preparation may be a cream, gel, ointment, skin emulsifier, skin suspension, transdermal delivery patch, drug-containing bandage, lotion, or a combination thereof.
  • the external skin preparation is a component usually used in external preparations for skin such as cosmetics or pharmaceuticals, for example, water-based components, oil-based components, powder components, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, and fragrances. , colorants, various skin nutrients, or combinations thereof and may be suitably blended as needed.
  • the external skin preparations include metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid, caffeine, tannin, bellapamil, licorice extract, glabridin, and calin.
  • Hot-water extracts of fruits, various herbal medicines, tocopherol acetate, glycyrrhizic acid, tranexamic acid and its derivatives or salts and other drugs, vitamin C, magnesium ascorbate phosphate, ascorbic acid glucoside, arbutin, kojic acid, glucose, fructose, Sugars, such as trehalose, etc. can also be mix
  • the composition may be a pharmaceutical composition.
  • the pharmaceutical composition may additionally include a pharmaceutically acceptable diluent or carrier.
  • the diluent may be lactose, corn starch, soybean oil, microcrystalline cellulose, or mannitol, and magnesium stearate, talc, or a combination thereof as a lubricant.
  • the carrier may be an excipient, a disintegrant, a binder, a lubricant, or a combination thereof.
  • the excipient may be microcrystalline cellulose, lactose, low-substituted hydroxycellulose, or a combination thereof.
  • the disintegrant may be calcium carboxymethylcellulose, sodium starch glycolate, calcium monohydrogen phosphate, or a combination thereof.
  • the binder may be polyvinylpyrrolidone, low-substituted hydroxypropylcellulose, hydroxypropylcellulose, or a combination thereof.
  • the lubricant may be magnesium stearate, silicon dioxide, talc, or a combination thereof.
  • the pharmaceutical composition may be formulated for oral or parenteral administration.
  • Oral dosage forms may be granules, powders, solutions, tablets, capsules, dry syrups, or combinations thereof.
  • Parenteral dosage forms may be injections.
  • the composition may be a health functional food composition.
  • the health functional food composition may be used alone or in combination with other foods or food ingredients, and may be appropriately used according to conventional methods.
  • the mixing amount of the active ingredient may be appropriately determined depending on the purpose of use (prevention, health or therapeutic treatment).
  • the composition of the present specification may be added in an amount of 15 parts by weight or less based on the raw material.
  • beverage compositions may contain various flavoring agents or natural carbohydrates as additional components, like conventional beverages.
  • the natural carbohydrates include monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol.
  • sweetener natural sweeteners such as thaumatin and stevia extract, or synthetic sweeteners such as saccharin and aspartame may be used.
  • the health food composition may also contain nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, and carbonated beverages. carbonation agent used, or a combination thereof.
  • the health functional food composition may also contain natural fruit juice, fruit juice beverages, fruit flesh for preparing vegetable beverages, or a combination thereof.
  • Another aspect also provides a method of preventing, ameliorating, or treating a condition in a subject comprising treating or administering to a subject in need thereof an effective amount of a composition described above.
  • the condition of the subject may be a skin related condition.
  • administering As used herein, the terms “administering,” “introducing,” and “implanting” are used interchangeably and according to one embodiment into a subject by a method or route that results in at least partial localization of a composition to a desired site. It may mean the arrangement of the composition according to one embodiment of.
  • Administration may be administered by a method known in the art.
  • Administration can be administered directly to a subject by any means, for example, by routes such as intravenous, intramuscular, oral, transdermal, mucosal, intranasal, intratracheal or subcutaneous administration.
  • routes such as intravenous, intramuscular, oral, transdermal, mucosal, intranasal, intratracheal or subcutaneous administration.
  • the administration may be administered systemically or locally.
  • the subject may be a mammal, such as a human, cow, horse, pig, dog, sheep, goat, or cat.
  • the subject may be a subject in need of skin condition improvement, for example, skin moisturizing, skin barrier strengthening, skin wound treatment, and skin wrinkle improvement.
  • the administration is 0.1 mg to 1,000 mg per day of the composition according to one embodiment, for example, 0.1 mg to 500 mg, 0.1 mg to 100 mg, 0.1 mg to 50 mg, 0.1 mg to 25 mg, 1 mg to 1,000 mg, 1 mg to 500 mg, 1 mg to 100 mg, 1 mg to 50 mg, 1 mg to 25 mg, 5 mg to 1,000 mg, 5 mg to 500 mg, 5 mg to 100 mg, 5 mg to 50 mg , 5 mg to 25 mg, 10 mg to 1,000 mg, 10 mg to 500 mg, 10 mg to 100 mg, 10 mg to 50 mg, or 10 mg to 25 mg may be administered.
  • the dosage may be variously prescribed depending on factors such as formulation method, administration method, patient's age, weight, sex, medical condition, food, administration time, administration route, excretion rate and response sensitivity, and those skilled in the art can Dosage can be appropriately adjusted in consideration of these factors.
  • the number of administrations can be once a day or two or more times within the range of clinically acceptable side effects, and administration can be done at one or two or more sites, daily or at intervals of 2 to 5 days, for a total of
  • the number of administration days may be administered from 1 day to 30 days per treatment. If necessary, the same treatment can be repeated after a titration period.
  • the same dosage per kg as for humans is used, or the above dosage is converted by the volume ratio (eg, average value) of the organ (heart, etc.) between the target animal and the human.
  • a single dose can be administered.
  • the cosmetic composition according to one aspect contains both a saffron flower extract and a Danshen root extract, and thus has a synergistic effect on wrinkles, elasticity, and moisturizing compared to each single extract, and thus has an excellent effect on improving skin conditions.
  • 1 is a photograph showing the color of a saffron flower extract with or without a decolorization process.
  • Figure 2 is a graph showing the effect of saffron flower extracts on the expression of MMP-1 according to the presence or absence of a crocin compound.
  • Figure 3 is a graph showing the effect of saffron flower extract on collagen production according to the presence or absence of a crocin compound.
  • Figure 4 is a result showing the effect of saffron flower extract on wound healing and skin regeneration according to the presence or absence of a crocin compound.
  • Figure 5 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of MMP-1.
  • Figure 6 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of COL1A1.
  • FIG. 7 is a graph showing the effect of the cosmetic composition according to one embodiment on the production of elastin.
  • FIG. 8 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of fibrillin.
  • 9A and 9B are results showing the skin regeneration promoting effect of the cosmetic composition according to one embodiment.
  • 10A and 10B are graphs showing the skin moisturizing effect of the cosmetic composition according to one embodiment.
  • 11A, 11B and 11C are results showing the skin wrinkle improvement effect according to the formulation of the cosmetic composition according to one embodiment.
  • the saffron flower dried extract prepared in Preparation Example 1 further included a step of decolorizing the colored material using a filtering agent to which 0.5 to 10% by weight of activated carbon was added based on the total weight of the solvent for 10 to 24 hours.
  • a saffron flower water extract was prepared in the same manner as in Preparation Example 1 except for the above.
  • Saffron flower dried extract water extract was prepared in the same manner as in Preparation Example 2, except that the saffron flower water extract prepared in Preparation Examples 3 and 5 was used.
  • Saffron flower ethanol extracts were prepared in the same manner as in Preparation Example 8, except that 25 ° C. ethanol (10%, 25% and 50%) was used.
  • a cosmetic composition was prepared by mixing the saffron flower water extract prepared in Preparation Example 2 and the Danshen root extract prepared in Preparation Example 14 at weight ratios of 1:0.1, 1:0.5, and 1:1.
  • a cosmetic composition in a cream formulation containing the ingredients and contents of Table 1 below was prepared. In this specification, unless otherwise indicated, content is % by weight.
  • a creamy cosmetic composition was prepared in the same manner as in Example 4, except that the components and contents of Table 2 were included.
  • the surface color of the saffron flower extract prepared in Preparation Examples 1 to 13 according to the decolorization process was visually observed.
  • the content of the crocin compound corresponding to the main component of the saffron flower extract was confirmed by HPTLC (High-Performance Thin Layer Chromatography) and shown in Table 3.
  • Preparation Example 1 Preparation Example 2 Preparation Example 3 Production Example 4 Preparation Example 5 Preparation Example 6 Preparation Example 7 Preparation Example 8 Preparation Example 9 Preparation Example 10 Preparation Example 11 Preparation Example 12 Preparation Example 13 crocin concentration +/- - +/- +/- +/- - - ++++ +/- +/- ++ ++++
  • 1 is a photograph showing the color of a saffron flower extract with or without a decolorization process.
  • the crocin compound which is a chemical substance responsible for the color of saffron, is removed by decolorization.
  • Saffron contains compounds such as crocin, picrocrocin, and safranal as main components. Therefore, it was confirmed whether a difference in anti-aging and anti-wrinkle activity occurs depending on the presence or absence of the crocin compound, which is one of the main components.
  • a human dermal fibroblast cell line Human dermal fibroblast, Hs68
  • UVA 10 J/cm 2 was irradiated or not irradiated through a Biosun UV lamp.
  • Preparation Example 2 and Preparation Example 9 were treated by concentration (1.0% and 2.0%), and further cultured for 48 hours. Then, the expression level of MMP-1 was measured by ELISA.
  • 10 ⁇ g/mL or 100 ⁇ g/mL of Crocin compound was used.
  • Figure 2 is a graph showing the effect of saffron flower extracts on the expression of MMP-1 according to the presence or absence of a crocin compound.
  • a human dermal fibroblast cell line Human dermal fibroblast, Hs68
  • Preparation Example 2 and Preparation Example 9 were treated by concentration (1.0% and 2.0%), and further cultured for 24 hours.
  • the culture supernatant was stored at -80 ° C, and the amount of collagen expression was measured by ELISA.
  • 10 ⁇ g/mL of Crocin compound was used.
  • Figure 3 is a graph showing the effect of saffron flower extract on collagen production according to the presence or absence of a crocin compound.
  • Preparation Example 2 and Preparation Example 9 was confirmed to increase the expression of collagen in a concentration-dependent manner.
  • the saffron flower extract according to one embodiment may exhibit an effect of improving skin elasticity regardless of the presence or absence of the crocin compound.
  • a human dermal fibroblast cell line (Hs68) was cultured in an incubator at 37° C. and 5% CO 2 to reach 100% confluency. Thereafter, using a pipette tip, randomly scrape across the center of the well to make a wound, and then replace the above Preparation Example 2 and Preparation Example 9 with a medium containing 1.0%, respectively, for an additional 24 hours. cultured. Then, cell migration of the fibroblasts was observed using an electron microscope. As a positive control group, 10 ⁇ g/mL of Crocin compound was used.
  • Figure 4 is a result showing the effect of saffron flower extract on wound healing and skin regeneration according to the presence or absence of a crocin compound.
  • the saffron flower extract according to one embodiment can not only treat skin wounds by promoting cell migration in aged fibroblasts, but also exhibit skin regeneration effects, even though it does not contain a crocin compound.
  • the saffron flower extract has a skin condition improvement effect regardless of the presence or absence of the crocin compound. Therefore, in the following, it was confirmed whether the mixture of the saffron flower extract and the Danshen root extract has synergistic activity of anti-aging and anti-wrinkle compared to each single extract.
  • human dermal fibroblast cell line Human dermal fibroblast, Hs68 was divided into 3x10 5 in a 6-well plate, and then cultured for 24 hours in an incubator at 37°C and 5% CO 2 conditions.
  • Figure 5 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of MMP-1.
  • Figure 6 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of COL1A1.
  • the cosmetic composition according to one aspect reduces the expression of MMP-1 increased by ultraviolet rays and increases the expression of COL1A1 by including a saffron flower extract and a Danshen root extract, thereby having excellent anti-aging and anti-wrinkle activity.
  • the human dermal fibroblast cell line Human dermal fibroblast, Hs68
  • FIG. 7 is a graph showing the effect of the cosmetic composition according to one embodiment on the production of elastin.
  • FIG. 8 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of fibrillin.
  • the cosmetic composition according to one aspect includes a saffron flower extract and a Danshen root extract, the expression of elastin and fibrillin is significantly increased compared to each single extract, and thus, a synergistic effect of improving skin elasticity can be exhibited.
  • the human dermal fibroblast cell line Human dermal fibroblast, Hs68
  • Hs68 human dermal fibroblast, Hs68
  • the medium was replaced with a medium containing 1.0% of Examples 1 to 3, respectively, and further cultured for 24 hours.
  • cell migration of the fibroblasts was observed using an electron microscope.
  • bEGF 10 ng/ml was used as a positive control group.
  • 9A and 9B are results showing the skin regeneration promoting effect of the cosmetic composition according to one embodiment.
  • the cosmetic composition according to one aspect may have excellent effects on wound healing and skin regeneration by including the saffron flower extract and the Danshen root extract.
  • Example 4 Comparative Example 1 twice a day for 4 weeks on the left/right side of the face. Then, the test site was washed with soap and waited in a constant temperature and humidity room (22 ⁇ 2 °C, 40 ⁇ 60% RH) for 10 minutes, and then the skin moisture level (0 weeks) was measured and skin wrinkles (0 weeks) were photographed. . After 2 weeks and 4 weeks of product use, skin moisture level and skin wrinkles were measured in the same way, and the average of the three measured values in each week was calculated and compared with the measured values in the 0th week.
  • 10A and 10B are graphs showing the skin moisturizing effect of the cosmetic composition according to one embodiment.
  • 11A, 11B and 11C are results showing the skin wrinkle improvement effect of the cosmetic composition according to one embodiment.
  • Example 4 As a result, as shown in FIGS. 10A and 10B, it was confirmed that the skin moisture level after 4 weeks of use was 24.3% and 5.0% in Example 4 and Comparative Example 1, respectively, and increased compared to before use. In particular, in Example 4, it was confirmed that the skin moisture level was significantly increased compared to Comparative Example 1.
  • Example 4 and Comparative Example 1 decreased skin indentation as the use time increased.
  • Example 4 it was confirmed that the rate of change in skin subsidence at the 4th week of use was significantly reduced compared to Comparative Example 1.
  • the cosmetic composition according to one aspect has an excellent effect on skin moisturizing and wrinkle improvement.

Abstract

The present invention pertains to a cosmetic composition comprising a saffron flower extract and a Danshen extract. A mixture of the saffron flower extract and the Danshen extract has a synergistic effect on wrinkles, elasticity, and moisturization, and thus has an excellent effect on improving skin beauty.

Description

샤프란 꽃 추출물 및 단삼 뿌리 추출물을 포함하는 화장료 조성물COSMETIC COMPOSITION COMPRISING Saffron Flower Extract and Danshen Root Extract
화장료 조성물에 관한 것이다.It relates to a cosmetic composition.
피부는 외부에서부터 순서대로 표피(Epidermis), 진피(Dermis), 피하지방(Hypodermis) 조직의 3개 층으로 크게 구분되며, 물리적, 화학적인 외부 환경의 자극으로부터 인체를 보호하는 기능을 한다. 이 중 표피는 다시 각질층, 과립층, 유극층, 기저층으로 나뉘는데, 각질층은 약 10~20%의 수분을 함유하며 인체의 최외곽에 존재함으로써 체외로의 수분 증발을 억제하는 한편, 외부로부터 물질의 과잉 침투를 차단하는 역할을 한다. 또한, 각질층 표면은 피지선에서 나온 피지와 땀샘에서 나온 땀으로 만들어진 얇은 천연 보호막으로 감싸져 있어 수분의 증발을 예방한다.The skin is largely divided into three layers of tissues, epidermis, dermis, and hypodermis, in order from the outside, and functions to protect the human body from physical and chemical external environmental stimuli. Among them, the epidermis is further divided into the stratum corneum, the granular layer, the prickle layer, and the basal layer. The stratum corneum contains about 10 to 20% of water and exists in the outermost part of the human body, suppressing the evaporation of moisture to the outside of the body and excessive substances from the outside. It acts as a barrier to penetration. In addition, the surface of the stratum corneum is covered with a thin natural protective film made of sebum from the sebaceous glands and sweat from the sweat glands to prevent evaporation of moisture.
노화된 피부에서 나타나는 주름살과 피부의 탄력 감소, 피부 처짐 및 건조 현상 등은 대부분 진피에 존재하는 기질단백질의 변화로 인해 발생한다. 진피는 피부 내에서 피부의 강도와 형태를 지지하는 역할을 하고 있는데, 노화가 진행될 때 진피에 형태적인 변화가 일어남으로써 주름 생성 및 피부 처짐에 결정적인 역할을 하는 것이다. 진피 층을 지지하는 역할을 하는 것이 콜라겐(Collagen)과 엘라스틴(Elastin)이며 이러한 기질단백질을 분해하는 효소로서 대표적인 것이 매트릭스 메탈로프로테아제(Matrix metalloproteinase, MMP)가 있다. 자외선 조사 시 피부 내의 MMPs 활성이 증가되고, 피부 내의 콜라겐 및 기타 기질단백질을 현저하게 분해시켜 피부 노화를 촉진하는데 주요한 요인으로 작용한다.Wrinkles, reduced skin elasticity, skin sagging and dryness appearing in aged skin are mostly caused by changes in matrix proteins present in the dermis. The dermis plays a role in supporting the strength and shape of the skin within the skin, and as aging progresses, morphological changes occur in the dermis, which plays a decisive role in wrinkle formation and skin sagging. Collagen and Elastin play a role in supporting the dermal layer, and matrix metalloproteinase (MMP) is a representative enzyme that decomposes these matrix proteins. When irradiated with ultraviolet rays, the activity of MMPs in the skin increases, and collagen and other matrix proteins in the skin are significantly decomposed, which acts as a major factor in promoting skin aging.
따라서, 콜라겐과 엘라스틴의 합성을 촉진하고 MMP-1를 억제하여 피부 노화 방지에 탁월한 천연 추출물 소재의 화장품 개발이 필요하다.Therefore, it is necessary to develop cosmetics with natural extracts that are excellent for preventing skin aging by promoting the synthesis of collagen and elastin and inhibiting MMP-1.
일 양상은 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 유효성분으로 포함하는 피부 상태 개선용 화장료 조성물을 제공하는 것이다. One aspect is to provide a cosmetic composition for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
다른 양상은 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 유효성분으로 포함하는 피부 상태 개선용 피부외용제용 조성물을 제공하는 것이다. Another aspect is to provide a composition for external application for skin for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
또 다른 양상은 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 유효성분으로 포함하는 피부 상태 개선용 건강기능식품 조성물을 제공하는 것이다.Another aspect is to provide a health functional food composition for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
일 양상은 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 유효성분으로 포함하는 피부 상태 개선용 조성물을 제공한다. One aspect provides a composition for improving skin conditions comprising a saffron flower extract and a Danshen root extract as active ingredients.
상기 샤프란(Crocus Sativus)은 꽃의 암술을 추출하여 제조한 건조 향신료로서, 크로신(crocin), 피크로크로신(picrocrocin), 사프라날(safranal), 크로세틴(crocetin) 등과 같은 화합물을 포함하고 있다. 상기 화합물 중 크로신은 글리코시드 혼합물로서 샤프란에 황적색의 색을 부여하며, 크로신의 주요 성분은 α-크로신이다. 일반적으로 샤프란 꽃은 암술 머리를 제거한 후 버려진다. 특히, 사프란 꽃 또한 암술과 같이 크로신 성분으로 인해 진한 붉은 색을 띠어 변색에 대한 위험성이 있어 화장품 효능 원료로 고농도 사용되기 어렵다는 문제가 있다. 일 실시예에서는 샤프란 꽃, 구체적으로 샤프란 꽃잎 추출물이 피부섬유아세포에서 자외선에 의해 증가된 MMP-1의 발현을 감소시키고, 콜라겐의 발현을 증가시키며, 노화된 섬유아세포에서 세포 이동을 촉진함으로써 피부 상처를 치료할 수 있을 뿐만 아니라, 피부 재생 효과를 나타내는 것을 확인하였다. 따라서, 상기 샤프란 꽃은 피부 미용 개선에 효과적인 각종 유효성분을 함유하고 있을 뿐만 아니라, 암술에 비하여 원가가 낮은 바, 대체 원료로 사용될 수 있다.The saffron ( Crocus Sativus ) is a dried spice prepared by extracting the pistil of a flower, and includes compounds such as crocin, picrocrocin, safranal, and crocetin. are doing Among the compounds, crocin is a glycoside mixture that gives saffron a yellow-red color, and the main component of crocin is α-crocin. Generally, saffron flowers are discarded after removing the stigma. In particular, saffron flowers, like pistils, have a deep red color due to the crocin component, so there is a risk of discoloration, so it is difficult to use them as cosmetic ingredients at high concentrations. In one embodiment, saffron flowers, specifically saffron petal extract, reduce the expression of MMP-1, which is increased by ultraviolet rays in skin fibroblasts, increase the expression of collagen, and promote cell migration in aged fibroblasts, thereby causing skin wounds. It was confirmed that not only can treat, but also exhibits a skin regeneration effect. Therefore, the saffron flower not only contains various active ingredients effective for improving skin beauty, but also has a lower cost compared to pistils, so it can be used as an alternative raw material.
상기 단삼(Salvia Miltiorrhiza)은 꿀풀과에 속하는 다년생 초본식물로서, 인삼의 형태와 유사하고 붉은 빛을 나타내며 인체 내 혈액순환을 촉진시키고 콜레스테롤을 낮추는 효과가 우수하다고 알려져 있다. Salvia Miltiorrhiza is a perennial herbaceous plant belonging to the Lamiaceae family, and is similar to ginseng in shape and is known to have a reddish color, promote blood circulation in the human body, and have excellent cholesterol-lowering effects.
상기 샤프란 꽃 추출물은 샤프란 꽃을 물, C1 내지 C4의 저급 알코올 또는 이들의 혼합물을 용매로 추출한 것으로, 상기 샤프란 꽃 추출물은 크로신 화합물을 포함할 수 있다. 샤프란 꽃을 세절한 후, 물, 알코올 또는 이들의 혼합물을 샤프란 꽃 무게의 2배 내지 20배를 첨가하여 추출하는 것일 수 있다. 또한, 상기 추출은 30℃ 내지 100℃에서 수행될 수 있으며, 1 내지 10시간 동안 추출되는 것일 수 있다. 추출 방법은 냉침, 초음파 추출 또는 환류 냉각 추출 방법 등을 이용할 수 있으며, 추출 횟수는 1회 내지 5회 동안 수행될 수 있다. The saffron flower extract is obtained by extracting saffron flowers with water, C1 to C4 lower alcohol, or a mixture thereof as a solvent, and the saffron flower extract may contain a crocin compound. After cutting the saffron flowers, it may be extracted by adding 2 to 20 times the weight of the saffron flowers with water, alcohol, or a mixture thereof. In addition, the extraction may be performed at 30 ° C to 100 ° C, and may be extracted for 1 to 10 hours. The extraction method may use cold needle extraction, ultrasonic extraction, or reflux cooling extraction method, and the number of extractions may be performed for 1 to 5 times.
일 구체예에 있어서, 상기 샤프란 꽃 추출물은 상기 샤프란 꽃을 물 및 탄수화물분해효소(carbonhydrase)의 혼합물을 용매로 추출하는 것일 수 있다. 일반적으로 탄수화물은 분자량이 크고 불용성인 바, 체내에 흡수가 어렵다는 문제점이 있다. 상기 탄수화물분해효소는 샤프란 꽃에 존재하는 탄수화물을 글루코스, 말토오스와 같은 단당류로 전환하는 반응을 촉매한다. 따라서, 일 구체예에 따른 샤프란 꽃 추출물은 분자량이 작은 단당류를 포함함으로써 샤프란 꽃의 유효성분의 피부 흡수를 촉진시키는 바, 피부 상태 개선 효과를 극대화시킬 수 있다. In one embodiment, the saffron flower extract may be obtained by extracting the saffron flower with a mixture of water and a carbonhydrase as a solvent. In general, since carbohydrates have a high molecular weight and are insoluble, there is a problem in that they are difficult to absorb into the body. The carbolytic enzyme catalyzes a reaction that converts carbohydrates present in saffron flowers into monosaccharides such as glucose and maltose. Therefore, the saffron flower extract according to one embodiment contains a monosaccharide having a low molecular weight to promote skin absorption of active ingredients of the saffron flower, thereby maximizing the skin condition improvement effect.
다른 구체예에 있어서, 상기 샤프란 꽃 추출물은 샤프란 꽃을 물 및 탄수화물분해효소(carbonhydrase)의 혼합물을 용매로 추출한 후, 화학적, 물리적, 전기적 또는 생물학적 방법에 의해 탈색한 것일 수 있다. 예를 들어, 상기 탈색은 여과제를 이용한 여과법에 의해 수행될 수 있다. 상기 탈색에 의하여 크로신 화합물이 제거되는 바, 변색에 대한 위험성이 없어 화장품에 고농도로 사용할 수 있다. In another embodiment, the saffron flower extract may be obtained by extracting saffron flowers with a mixture of water and a carbonhydrase as a solvent and decolorizing the saffron flowers by chemical, physical, electrical or biological methods. For example, the decolorization may be performed by a filtration method using a filtering agent. Since the crocin compound is removed by the decolorization, there is no risk of discoloration, so it can be used in cosmetics at a high concentration.
일 실시예에서는 크로신 화합물의 유무에 관계 없이 피부섬유아세포에서 자외선에 의해 증가된 MMP-1의 발현을 감소시키고, 콜라겐의 발현을 증가시키며, 노화된 섬유아세포에서 세포 이동을 촉진함으로써 피부 상처를 치료할 수 있을 뿐만 아니라, 피부 재생 효과를 나타내는 것을 확인하였다. 따라서, 일 구체예에 따른 조성물은 샤프란 꽃 추출물의 함량에 따라 크로신 화합물을 탈색하는 단계를 선택적으로 적용할 수 있다. 또한, 상기 조성물은 피부 장벽 강화, 피부 주름, 피부 탄력 또는 보습 효과를 가질 수 있다. In one embodiment, regardless of the presence or absence of the crocin compound, skin wounds are reduced by reducing the expression of MMP-1, which is increased by ultraviolet rays in skin fibroblasts, increasing the expression of collagen, and promoting cell migration in aged fibroblasts. It was confirmed that not only can be treated, but also exhibits a skin regeneration effect. Therefore, the composition according to one embodiment may selectively apply a step of decolorizing the crocin compound according to the content of the saffron flower extract. In addition, the composition may have skin barrier strengthening, skin wrinkles, skin elasticity or moisturizing effects.
본 명세서에서 용어 "피부 노화"란 나이가 들어가면서 피부에 나타나게 되는 유형과 무형상의 변화를 통틀어 말하는 것으로, 예컨대 표피 두께가 얇아지는 현상, 진피의 세포 수나 혈관 수, DNA 손상복구 능력, 세포교체주기, 상처 회복, 피부장벽기능, 표피의 수분 유지, 땀분비, 피지분비, 비타민D 생산, 물리적 손상방어, 화학물질 제거능력, 면역반응, 감각 기능, 체온조절의 감소를 말한다. As used herein, the term "skin aging" refers to both tangible and intangible changes that appear in the skin with age, such as thinning of the epidermis, number of cells or blood vessels in the dermis, DNA damage repair ability, cell replacement cycle, It refers to reduction in wound healing, skin barrier function, epidermal moisture retention, sweat secretion, sebum secretion, vitamin D production, physical damage defense, chemical substance elimination ability, immune response, sensory function, and thermoregulation.
상기 조성물은 외인성 요인 또는 내인성 요인에 의해 유발되는 피부 노화 개선용일 수 있다. 상기 외인성 요인은 여러 가지 외부 요인, 예컨대 자외선(광)을 말하고 내인성 요인은 연대기적 요인이라고도 지칭되며 주로 시간의 흐름에 의해 발생하는 요인을 말한다. 즉, 상기 피부 노화는 구체적으로는 자외선, 공해, 담배연기, 화학물질 등에 의한 외부 자극에 의해 유도되는 조기 노화 증상 뿐만 아니라, 나이가 들어감에 의해 피부세포의 증식이 감소함에 따라 발생하는 자연노화 현상을 포함하며 주름, 탄력 감소, 피부 쳐짐 및 건조 현상 등을 모두 포함하는 개념이다. 또한 주름은 내ㆍ외부 요인의 변화에 의한 자극이 피부조직을 구성하고 있는 성분을 변화시켜 주름을 유발하는 것을 포함한다. The composition may be used to improve skin aging caused by exogenous factors or endogenous factors. The extrinsic factor refers to various external factors, such as ultraviolet rays (light), and the endogenous factor is also referred to as a chronological factor and refers to a factor mainly caused by the passage of time. That is, the skin aging is not only premature aging symptoms induced by external stimuli such as ultraviolet rays, pollution, cigarette smoke, chemicals, etc., but also a natural aging phenomenon that occurs as the proliferation of skin cells decreases with age. It is a concept that includes wrinkles, loss of elasticity, skin sagging and dryness. In addition, wrinkles include stimulation caused by changes in internal and external factors that cause wrinkles by changing components constituting skin tissue.
상기 노화는 광노화일 수 있다. 용어 "광노화(Photoaging)"는 외부 환경적인 요인에 의해 유발되는 현상으로, 가장 대표적인 인자로는 자외선이 있다. 자외선은 단백질 분해효소의 활성화와 기질단백질의 사슬절단 및 비정상적인 교차결합 등의 생체 구성 성분들의 손상을 가져오고, 이러한 메커니즘의 반복은 외관상으로도 확연한 피부노화를 초래하게 된다. The aging may be photoaging. The term "photoaging" is a phenomenon caused by external environmental factors, and the most representative factor is ultraviolet rays. Ultraviolet rays cause damage to biocomponents such as activation of proteolytic enzymes, chain scission of matrix proteins, and abnormal cross-linking, and repetition of these mechanisms results in apparent skin aging.
본 명세서에서 용어 "주름"은 피부의 탄력성이 상실되어 느슨해진 상태를 의미하며, 예를 들면 피부가 접히는 것일 수 있다. 상기 "피부 주름 예방 또는 개선"이란 주름과 관련된 인자의 발현을 억제하여 주름을 방지 또는 개선하거나, 콜라겐 총량을 증가시키는 모든 작용을 의미할 수 있다.In this specification, the term "wrinkle" refers to a state in which elasticity of the skin is lost and loosened, and for example, the skin may be folded. The "prevention or improvement of skin wrinkles" may mean any action of preventing or improving wrinkles by suppressing the expression of wrinkle-related factors or increasing the total amount of collagen.
상기 "피부 장벽 강화"는 피부 가장 바깥쪽에 위치하여 수분과 영양 손실을 막아주는 피부 장벽의 기능이 증진되는 모든 작용을 의미할 수 있다. 피부 장벽 기능 손상은 피부 장벽의 기능이 저하되거나 손상되어 피부에 나타나는 모든 변화를 의미할 수 있다. 예를 들어, 피부 주름 증가, 건조, 피부염, 아토피 피부염, 알레르기성 피부염, 여드름 등을 포함할 수 있다.The "strengthen the skin barrier" may refer to any action that enhances the function of the skin barrier, which is located at the outermost layer of the skin and prevents loss of moisture and nutrients. Impaired skin barrier function may refer to any changes that occur in the skin due to reduced or damaged skin barrier function. Examples include increased skin wrinkling, dryness, dermatitis, atopic dermatitis, allergic dermatitis, acne, and the like.
상기 "피부 보습"은 피부 수분을 유지하거나 수분 손실을 방지하는 모든 작용을 의미할 수 있다.The "moisturizing skin" may refer to any action that maintains skin moisture or prevents moisture loss.
상기 단삼 추출물은 단삼을 물, C1 내지 C4의 저급 알코올 또는 이들의 혼합물을 용매로 추출한 것일 수 있다. 단삼 뿌리를 세절한 후, 물, 알코올 또는 이들의 혼합물을 단삼 뿌리 무게의 2배 내지 20배를 첨가하여 추출하는 것일 수 있다. 또한, 상기 추출은 30℃ 내지 100℃에서 수행될 수 있으며, 1 내지 10시간 동안 추출되는 것일 수 있다. 추출 방법은 냉침, 초음파 추출 또는 환류 냉각 추출 방법 등을 이용할 수 있으며, 추출 횟수는 1회 내지 5회 동안 수행될 수 있다.The Danshen extract may be obtained by extracting Danshen with water, C1 to C4 lower alcohol, or a mixture thereof as a solvent. After cutting the Danshen root, it may be extracted by adding 2 to 20 times the weight of the Danshen root with water, alcohol, or a mixture thereof. In addition, the extraction may be performed at 30 ° C to 100 ° C, and may be extracted for 1 to 10 hours. The extraction method may use cold needle extraction, ultrasonic extraction, or reflux cooling extraction method, and the number of extractions may be performed for 1 to 5 times.
일 구체예에 있어서, 상기 샤프란 꽃 추출물 및 단삼 뿌리 추출물은 1:0.01 내지 1:10의 중량비로 혼합된 것일 수 있다. 상기 샤프란 꽃 추출물 및 단삼 뿌리 추출물은 예를 들어, 1:0.01 내지 1:10, 1:0.1 내지 1:10, 1:1 내지 1:10, 1:5 내지 1:10, 1:5 내지 1:8 또는 1:7 내지 1:9로 혼합될 수 있다. 이때, 상기 샤프란 꽃 추출물 및 단삼 뿌리 추출물의 혼합 비율이 상기 범위 미만인 경우, 샤프란 꽃 추출물 및 단삼 뿌리 추출물에 의한 피부 상태 개선의 시너지 효과가 충분히 발휘되지 못하는 문제점이 있다. In one embodiment, the saffron flower extract and Danshen root extract may be mixed in a weight ratio of 1:0.01 to 1:10. The saffron flower extract and Danshen root extract are, for example, 1:0.01 to 1:10, 1:0.1 to 1:10, 1:1 to 1:10, 1:5 to 1:10, 1:5 to 1 :8 or 1:7 to 1:9. At this time, when the mixing ratio of the saffron flower extract and the Danshen root extract is less than the above range, there is a problem in that the synergistic effect of improving skin condition by the saffron flower extract and the Danshen root extract is not sufficiently exhibited.
다른 구체예에 있어서, 상기 조성물은 조성물 총 중량에 대하여 0.001 중량% 내지 80 중량%, 예를 들면, 0.01 중량% 내지 60 중량%, 0.01 중량% 내지 40 중량%, 0.01 중량% 내지 30 중량%, 0.01 중량% 내지 20 중량%, 0.01 중량% 내지 10 중량%, 0.01 중량% 내지 5 중량%, 0.05 중량% 내지 60 중량%, 0.05 중량% 내지 40 중량%, 0.05 중량% 내지 30 중량%, 0.05 중량% 내지 20 중량%, 0.05 중량% 내지 10 중량%, 0.05 중량% 내지 5 중량%, 0.1 중량% 내지 60 중량%, 0.1 중량% 내지 40 중량%, 0.1 중량% 내지 30 중량%, 0.1 중량% 내지 20 중량%, 0.1 중량% 내지 10 중량%, 또는 0.1 중량% 내지 5 중량%의 샤프란 꽃 추출물 및 단삼 뿌리 추출물의 혼합물을 포함할 수 있다.In another embodiment, the composition is 0.001% to 80% by weight, for example, 0.01% to 60% by weight, 0.01% to 40% by weight, 0.01% to 30% by weight, based on the total weight of the composition, 0.01% to 20% by weight, 0.01% to 10% by weight, 0.01% to 5% by weight, 0.05% to 60% by weight, 0.05% to 40% by weight, 0.05% to 30% by weight, 0.05% by weight % to 20% by weight, 0.05% to 10% by weight, 0.05% to 5% by weight, 0.1% to 60% by weight, 0.1% to 40% by weight, 0.1% to 30% by weight, 0.1% to 0.1% by weight 20% by weight, 0.1% to 10% by weight, or 0.1% to 5% by weight of a mixture of saffron flower extract and Danshen root extract.
일 실시예에서는 샤프란 꽃 추출물 및 단삼 뿌리 추출물의 혼합물이 각각의 단독 추출물에 비해 자외선에 의해 증가된 MMP-1의 발현을 감소시키고, COL1A1, 엘라스틴 및 피브릴린 발현을 증가시키는 것을 확인하였다. 또한, 상처가 유발된 섬유아세포의 회복에 현저한 효과를 나타내는 것을 확인하였다. 따라서, 일 양상에 따른 조성물은 샤프란 꽃 추출물 및 단삼 뿌리 추출물의 혼합물에 의해 피부 미용 개선, 상처 치유 효과의 시너지 활성을 가질 수 있다. In one embodiment, it was confirmed that the mixture of the saffron flower extract and the Danshen root extract reduced the expression of MMP-1 increased by UV light and increased the expression of COL1A1, elastin and fibrillin, compared to each extract alone. In addition, it was confirmed that it exhibits a remarkable effect on the recovery of wound-induced fibroblasts. Therefore, the composition according to one aspect may have a synergistic activity of improving skin beauty and wound healing by the mixture of the saffron flower extract and the Danshen root extract.
상기 조성물은 화장료 조성물일 수 있다. The composition may be a cosmetic composition.
상기 화장료 조성물은 예를 들면, 유연화장수, 영양화장수, 마사지크림, 영양크림, 에센스, 팩, 젤, 앰플 또는 피부 점착 타입의 화장료 제형을 갖는 것일 수 있다.The cosmetic composition may have, for example, softening lotion, nutrient lotion, massage cream, nutrient cream, essence, pack, gel, ampoule, or skin-adhesive cosmetic formulation.
상기 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 조성물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함할 수 있다.Ingredients included in the cosmetic composition may include ingredients commonly used in cosmetic compositions other than the composition as active ingredients, for example, conventional adjuvants and carriers such as stabilizers, solubilizers, vitamins, pigments and flavors. can include
또한, 상기 조성물은 피부외용제용 조성물일 수 있다. In addition, the composition may be a composition for external application for skin.
상기 피부외용제는 크림, 겔, 연고, 피부 유화제, 피부 현탁액, 경피전달성 패치, 약물 함유 붕대, 로션, 또는 그 조합일 수 있다. 상기 피부외용제는 통상 화장품이나 의약품 등의 피부외용제에 사용되는 성분, 예를 들면 수성성분, 유성성분, 분말성분, 알코올류, 보습제, 증점제, 자외선흡수제, 미백제, 방부제, 산화방지제, 계면활성제, 향료, 색제, 각종 피부 영양제, 또는 이들의 조합과 필요에 따라서 적절하게 배합될 수 있다. 상기 피부외용제는, 에데트산이나트륨, 에데트산삼나트륨, 시트르산나트륨, 폴리인산나트륨, 메타인산나트륨, 글루콘산 등의 금속봉쇄제, 카페인, 탄닌, 벨라파밀, 감초추출물, 글라블리딘, 칼린의 과실의 열수추출물, 각종생약, 아세트산토코페롤, 글리틸리틴산, 트라넥삼산 및 그 유도체 또는 그 염등의 약제, 비타민 C, 아스코르브산인산마그네슘, 아스코르브산글루코시드, 알부틴, 코지산, 글루코스, 프룩토스, 트레할로스 등의 당류등도 적절하게 배합할 수 있다.The external skin preparation may be a cream, gel, ointment, skin emulsifier, skin suspension, transdermal delivery patch, drug-containing bandage, lotion, or a combination thereof. The external skin preparation is a component usually used in external preparations for skin such as cosmetics or pharmaceuticals, for example, water-based components, oil-based components, powder components, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, and fragrances. , colorants, various skin nutrients, or combinations thereof and may be suitably blended as needed. The external skin preparations include metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid, caffeine, tannin, bellapamil, licorice extract, glabridin, and calin. Hot-water extracts of fruits, various herbal medicines, tocopherol acetate, glycyrrhizic acid, tranexamic acid and its derivatives or salts and other drugs, vitamin C, magnesium ascorbate phosphate, ascorbic acid glucoside, arbutin, kojic acid, glucose, fructose, Sugars, such as trehalose, etc. can also be mix|blended suitably.
다른 구체예에 있어서, 상기 조성물은 약학적 조성물일 수 있다. In another embodiment, the composition may be a pharmaceutical composition.
상기 약학적 조성물은 약제학적으로 허용가능한 희석제 또는 담체를 추가적으로 포함할 수 있다. 상기 희석제는 유당, 옥수수 전분, 대두유, 미정질 셀룰로오스, 또는 만니톨, 활택제로는 스테아린산 마그네슘, 탈크, 또는 그 조합일 수 있다. 상기 담체는 부형제, 붕해제, 결합제, 활택제, 또는 그 조합일 수 있다. 상기 부형제는 미결정 셀룰로오즈, 유당, 저치환도 히드록시셀룰로오즈, 또는 그 조합일 수 있다. 상기 붕해제는 카르복시메틸셀룰로오스 칼슘, 전분글리콜산 나트륨, 무수인산일수소 칼슘, 또는 그 조합일 수 있다. 상기 결합제는 폴리비닐피롤리돈, 저치환도 히드록시프로필셀룰로오즈, 히드록시프로필셀룰로오즈, 또는 그 조합일 수 있다. 상기 활택제는 스테아린산 마그네슘, 이산화규소, 탈크, 또는 그 조합일 수 있다.The pharmaceutical composition may additionally include a pharmaceutically acceptable diluent or carrier. The diluent may be lactose, corn starch, soybean oil, microcrystalline cellulose, or mannitol, and magnesium stearate, talc, or a combination thereof as a lubricant. The carrier may be an excipient, a disintegrant, a binder, a lubricant, or a combination thereof. The excipient may be microcrystalline cellulose, lactose, low-substituted hydroxycellulose, or a combination thereof. The disintegrant may be calcium carboxymethylcellulose, sodium starch glycolate, calcium monohydrogen phosphate, or a combination thereof. The binder may be polyvinylpyrrolidone, low-substituted hydroxypropylcellulose, hydroxypropylcellulose, or a combination thereof. The lubricant may be magnesium stearate, silicon dioxide, talc, or a combination thereof.
상기 약학적 조성물은 경구 또는 비경구 투여 제형으로 제형화될 수 있다. 경구 투여 제형은 과립제, 산제, 액제, 정제, 캅셀제, 건조시럽제, 또는 그 조합일 수 있다. 비경구 투여 제형은 주사제일 수 있다.The pharmaceutical composition may be formulated for oral or parenteral administration. Oral dosage forms may be granules, powders, solutions, tablets, capsules, dry syrups, or combinations thereof. Parenteral dosage forms may be injections.
상기 조성물은 건강기능식품 조성물일 수 있다. The composition may be a health functional food composition.
상기 건강기능식품 조성물은 상기 조성물 단독 또는 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 사용 목적 (예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 명세서의 조성물은 원료에 대하여 15 중량부 이하의 양으로 첨가될 수 있다. 상기 건강기능식품의 종류에는 특별한 제한은 없다. 건강기능식품의 종류 중 음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 건강식품 조성물은 또한 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제, 또는 그 조합을 함유할 수 있다. 상기 건강기능식품 조성물은 또한, 천연 과일쥬스, 과일쥬스 음료, 야채 음료의 제조를 위한 과육, 또는 그 조합을 함유할 수 있다.The health functional food composition may be used alone or in combination with other foods or food ingredients, and may be appropriately used according to conventional methods. The mixing amount of the active ingredient may be appropriately determined depending on the purpose of use (prevention, health or therapeutic treatment). In general, when preparing food or beverage, the composition of the present specification may be added in an amount of 15 parts by weight or less based on the raw material. There is no particular limitation on the type of health functional food. Among the types of health functional foods, beverage compositions may contain various flavoring agents or natural carbohydrates as additional components, like conventional beverages. The natural carbohydrates include monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as thaumatin and stevia extract, or synthetic sweeteners such as saccharin and aspartame may be used. The health food composition may also contain nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, and carbonated beverages. carbonation agent used, or a combination thereof. The health functional food composition may also contain natural fruit juice, fruit juice beverages, fruit flesh for preparing vegetable beverages, or a combination thereof.
또한, 다른 양상은 유효한 양의 상기한 조성물을 그를 필요로 하는 개체에 처리 또는 투여하는 단계를 포함하는 개체의 상태를 예방, 개선, 또는 치료하는 방법을 제공한다. Another aspect also provides a method of preventing, ameliorating, or treating a condition in a subject comprising treating or administering to a subject in need thereof an effective amount of a composition described above.
상기 개체의 상태는 피부와 관련된 상태일 수 있다. The condition of the subject may be a skin related condition.
본 명세서에서 용어, "투여하는", "도입하는", 및 "이식하는"은 상호교환적으로 사용되고 일 구체예에 따른 조성물의 원하는 부위로의 적어도 부분적 국소화를 초래하는 방법 또는 경로에 의한 개체 내로의 일 구체예에 따른 조성물의 배치를 의미할 수 있다. As used herein, the terms "administering," "introducing," and "implanting" are used interchangeably and according to one embodiment into a subject by a method or route that results in at least partial localization of a composition to a desired site. It may mean the arrangement of the composition according to one embodiment of.
투여는 당업계에 알려진 방법에 의하여 투여될 수 있다. 투여는 예를 들면, 정맥내, 근육내, 경구, 경피 (transdermal), 점막, 코안 (intranasal), 기관내 (intratracheal) 또는 피하 투여와 같은 경로로, 임의의 수단에 의하여 개체로 직접적으로 투여될 수 있다. 상기 투여는 전신적으로 또는 국부적으로 투여될 수 있다.Administration may be administered by a method known in the art. Administration can be administered directly to a subject by any means, for example, by routes such as intravenous, intramuscular, oral, transdermal, mucosal, intranasal, intratracheal or subcutaneous administration. can The administration may be administered systemically or locally.
상기 개체는 포유동물, 예를 들면, 사람, 소, 말, 돼지, 개, 양, 염소, 또는 고양이일 수 있다. 상기 개체는 피부 상태 개선, 예를 들어 피부 보습, 피부 장벽 강화, 피부 상처 치료, 피부 주름 개선 효과를 필요로 하는 개체일 수 있다.The subject may be a mammal, such as a human, cow, horse, pig, dog, sheep, goat, or cat. The subject may be a subject in need of skin condition improvement, for example, skin moisturizing, skin barrier strengthening, skin wound treatment, and skin wrinkle improvement.
상기 투여는 일 구체예에 따른 조성물을 개체당 일당 0.1 ㎎ 내지 1,000 ㎎, 예를 들면, 0.1 ㎎ 내지 500 ㎎, 0.1 ㎎ 내지 100 ㎎, 0.1 ㎎ 내지 50 ㎎, 0.1 ㎎ 내지 25 ㎎, 1 ㎎ 내지 1,000 ㎎, 1 ㎎ 내지 500 ㎎, 1 ㎎ 내지 100 ㎎, 1 ㎎ 내지 50 ㎎, 1 ㎎ 내지 25 ㎎, 5 ㎎ 내지 1,000 ㎎, 5 ㎎ 내지 500 ㎎, 5 ㎎ 내지 100 ㎎, 5 ㎎ 내지 50 ㎎, 5 ㎎ 내지 25 ㎎, 10 ㎎ 내지 1,000 ㎎, 10 ㎎ 내지 500 ㎎, 10 ㎎ 내지 100 ㎎, 10 ㎎ 내지 50 ㎎, 또는 10 ㎎ 내지 25 ㎎을 투여하는 것일 수 있다. 다만, 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성별, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있고, 당업자라면 이러한 요인들을 고려하여 투여량을 적절히 조절할 수 있다. 투여 횟수는 1일 1회 또는 임상적으로 용인 가능한 부작용의 범위 내에서 2회 이상이 가능하고, 투여 부위에 대해서도 1개소 또는 2개소 이상에 투여할 수 있으며, 매일 또는 2 내지 5일 간격으로 총 투여 일수는 한번 치료 시 1일에서 30일까지 투여될 수 있다. 필요한 경우, 적정 시기 이후에 동일한 치료를 반복할 수 있다. 인간 이외의 동물에 대해서도, kg당 인간과 동일한 투여량으로 하거나, 또는 예를 들면 목적의 동물과 인간과의 기관(심장 등)의 용적비(예를 들면, 평균값) 등으로 상기의 투여량을 환산한 양을 투여할 수 있다.The administration is 0.1 mg to 1,000 mg per day of the composition according to one embodiment, for example, 0.1 mg to 500 mg, 0.1 mg to 100 mg, 0.1 mg to 50 mg, 0.1 mg to 25 mg, 1 mg to 1,000 mg, 1 mg to 500 mg, 1 mg to 100 mg, 1 mg to 50 mg, 1 mg to 25 mg, 5 mg to 1,000 mg, 5 mg to 500 mg, 5 mg to 100 mg, 5 mg to 50 mg , 5 mg to 25 mg, 10 mg to 1,000 mg, 10 mg to 500 mg, 10 mg to 100 mg, 10 mg to 50 mg, or 10 mg to 25 mg may be administered. However, the dosage may be variously prescribed depending on factors such as formulation method, administration method, patient's age, weight, sex, medical condition, food, administration time, administration route, excretion rate and response sensitivity, and those skilled in the art can Dosage can be appropriately adjusted in consideration of these factors. The number of administrations can be once a day or two or more times within the range of clinically acceptable side effects, and administration can be done at one or two or more sites, daily or at intervals of 2 to 5 days, for a total of The number of administration days may be administered from 1 day to 30 days per treatment. If necessary, the same treatment can be repeated after a titration period. For non-human animals, the same dosage per kg as for humans is used, or the above dosage is converted by the volume ratio (eg, average value) of the organ (heart, etc.) between the target animal and the human. A single dose can be administered.
일 양상에 따른 화장료 조성물은 사프란 꽃 추출물과 단삼 뿌리 추출물을 모두 포함하고 있어 각각의 단독 추출물에 비해 주름, 탄력, 보습 시너지 효과를 가지는 바, 피부 상태 개선에 탁월한 효과가 있다.The cosmetic composition according to one aspect contains both a saffron flower extract and a Danshen root extract, and thus has a synergistic effect on wrinkles, elasticity, and moisturizing compared to each single extract, and thus has an excellent effect on improving skin conditions.
도 1은 탈색 과정 유무에 따른 샤프란 꽃 추출물의 색을 나타낸 사진이다. 1 is a photograph showing the color of a saffron flower extract with or without a decolorization process.
도 2는 크로신 화합물의 유무에 따른 샤프란 꽃 추출물이 MMP-1의 발현에 미치는 영향을 나타낸 그래프이다.Figure 2 is a graph showing the effect of saffron flower extracts on the expression of MMP-1 according to the presence or absence of a crocin compound.
도 3은 크로신 화합물의 유무에 따른 샤프란 꽃 추출물이 콜라겐 생성에 미치는 영향을 나타낸 그래프이다.Figure 3 is a graph showing the effect of saffron flower extract on collagen production according to the presence or absence of a crocin compound.
도 4는 크로신 화합물의 유무에 따른 샤프란 꽃 추출물이 상처 치유 및 피부 재생에 미치는 영향을 나타낸 결과이다. Figure 4 is a result showing the effect of saffron flower extract on wound healing and skin regeneration according to the presence or absence of a crocin compound.
도 5는 일 구체예에 따른 화장료 조성물이 MMP-1의 발현에 미치는 영향을 나타낸 그래프이다. Figure 5 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of MMP-1.
도 6은 일 구체예에 따른 화장료 조성물이 COL1A1의 발현에 미치는 영향을 나타낸 그래프이다.Figure 6 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of COL1A1.
도 7은 일 구체예에 따른 화장료 조성물이 엘라스틴의 생성에 미치는 영향을 나타낸 그래프이다. 7 is a graph showing the effect of the cosmetic composition according to one embodiment on the production of elastin.
도 8은 일 구체예에 따른 화장료 조성물이 피브릴린의 발현에 미치는 영향을 나타낸 그래프이다. 8 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of fibrillin.
도 9A 및 도 9B는 일 구체예에 따른 화장료 조성물의 피부 재생 촉진 효과를 나타낸 결과이다. 9A and 9B are results showing the skin regeneration promoting effect of the cosmetic composition according to one embodiment.
도 10A 및 도 10B는 일 구체예에 따른 화장료 조성물의 피부 보습 효과를 나타낸 그래프이다. 10A and 10B are graphs showing the skin moisturizing effect of the cosmetic composition according to one embodiment.
도 11A, 도 11B 및 도 11C는 일 구체예에 따른 화장료 조성물의 제형에 따른 피부 주름 개선 효과를 나타낸 결과이다.11A, 11B and 11C are results showing the skin wrinkle improvement effect according to the formulation of the cosmetic composition according to one embodiment.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 하기 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, a preferred embodiment is presented to aid understanding of the present invention. However, the following examples are provided to more easily understand the present invention, and the content of the present invention is not limited by the following examples.
[제조예][Production Example]
제조예 1. 샤프란 꽃 물 추출물의 제조(1)Preparation Example 1. Preparation of saffron flower water extract (1)
건조 샤프란 꽃 16.7 g에 물 1L 및 탄수화물분해효소(carbonhydrase)를 가하여 25℃에서 24시간 동안 환류 냉각 추출하였다. 이를 여과지(Advantec no. 2 filter paper)를 이용하여 여과한 다음, 여액을 감압농축기(EYELA사, N-1000, 일본)를 이용하여 감압농축하여 샤프란 꽃 물 추출물을 제조하였다. 1 L of water and carbonhydrase were added to 16.7 g of dried saffron flowers, followed by reflux cooling and extraction at 25° C. for 24 hours. This was filtered using filter paper (Advantec no. 2 filter paper), and then the filtrate was concentrated under reduced pressure using a vacuum concentrator (EYELA Co., N-1000, Japan) to prepare a saffron flower water extract.
제조예 2. 샤프란 꽃 물 추출물의 제조(2)Preparation Example 2. Preparation of saffron flower water extract (2)
상기 제조예 1에서 제조한 샤프란 꽃 건조 엑스 추출물을 10 내지 24시간 동안 용매 총 중량에 대하여 0.5 내지 10 중량%의 활성탄을 첨가한 여과제를 이용하여 착색 물질을 탈색하는 단계를 추가로 포함하였다는 점을 제외하고는 상기 제조예 1과 동일한 방법으로 샤프란 꽃 물 추출물을 제조하였다. The saffron flower dried extract prepared in Preparation Example 1 further included a step of decolorizing the colored material using a filtering agent to which 0.5 to 10% by weight of activated carbon was added based on the total weight of the solvent for 10 to 24 hours. A saffron flower water extract was prepared in the same manner as in Preparation Example 1 except for the above.
제조예 3~5. 샤프란 꽃 물 추출물의 제조(3)Manufacturing Examples 3 to 5. Preparation of saffron flower water extract (3)
건조 샤프란 꽃 12.0 g에 다양한 온도(25℃, 50℃ 및 80℃)의 물 1 L를 가하여 24시간 동안 환류 냉각 추출하였다. 이를 여과지(Advantec no. 2 filter paper)를 이용하여 여과한 다음, 여액을 감압농축기(EYELA사, N-1000, 일본)를 이용하여 감압농축하여 샤프란 꽃 물 추출물을 제조하였다.To 12.0 g of dried saffron flowers, 1 L of water at various temperatures (25° C., 50° C., and 80° C.) was added, followed by reflux cooling and extraction for 24 hours. This was filtered using filter paper (Advantec no. 2 filter paper), and then the filtrate was concentrated under reduced pressure using a vacuum concentrator (EYELA Co., N-1000, Japan) to prepare a saffron flower water extract.
제조예 6~7. 샤프란 꽃 물 추출물의 제조(4)Manufacturing Examples 6 to 7. Preparation of saffron flower water extract (4)
상기 제조예 3 및 5에서 제조한 샤프란 꽃 물 추출물을 사용하였다는 점을 제외하고는 상기 제조예 2와 동일한 방법으로 샤프란 꽃 건조 엑스 물 추출물을 제조하였다.Saffron flower dried extract water extract was prepared in the same manner as in Preparation Example 2, except that the saffron flower water extract prepared in Preparation Examples 3 and 5 was used.
제조예 8~10. 샤프란 꽃 알코올 추출물의 제조(5)Production Examples 8 to 10. Preparation of Saffron Flower Alcohol Extract (5)
건조 샤프란 꽃 10 g에 다양한 농도(25%, 50% 및 75%)의 부틸렌글리콜 1 L를 가하여 50℃에서 24시간 동안 환류 냉각 추출하였다. 이를 여과지(Advantec no. 2 filter paper)를 이용하여 여과한 다음, 여액을 감압농축기(EYELA사, N-1000, 일본)를 이용하여 감압농축하여 건조된 상태의 샤프란 꽃 부틸렌글리콜 추출물을 제조하였다.1 L of butylene glycol of various concentrations (25%, 50%, and 75%) was added to 10 g of dried saffron flowers, followed by reflux cooling and extraction at 50° C. for 24 hours. This was filtered using filter paper (Advantec no. 2 filter paper), and then the filtrate was concentrated under reduced pressure using a vacuum concentrator (EYELA, N-1000, Japan) to prepare a dried saffron flower butylene glycol extract. .
제조예 11~13. 샤프란 꽃 알코올 추출물의 제조(6)Production Examples 11 to 13. Preparation of Saffron Flower Alcohol Extract (6)
25℃ 에탄올(10%, 25% 및 50%)를 사용하였다는 점을 제외하고는 상기 제조예 8과 동일한 방법으로 샤프란 꽃 에탄올 추출물을 제조하였다. Saffron flower ethanol extracts were prepared in the same manner as in Preparation Example 8, except that 25 ° C. ethanol (10%, 25% and 50%) was used.
제조예 14. 단삼 뿌리 추출물의 제조Preparation Example 14. Preparation of Danshen root extract
단삼 뿌리 분말가루 100 g에 25% 부틸렌글리콜 1 L를 가하여 25℃에서 24시간 동안 환류 냉각 추출하였다. 이를 여과지(Advantec no. 2 filter paper)를 이용하여 여과한 다음, 여액을 감압농축기(EYELA사, N-1000, 일본)를 이용하여 감압농축하여 단삼 뿌리 추출물을 제조하였다.1 L of 25% butylene glycol was added to 100 g of Danshen root powder, followed by reflux cooling and extraction at 25° C. for 24 hours. This was filtered using a filter paper (Advantec no. 2 filter paper), and then the filtrate was concentrated under reduced pressure using a vacuum concentrator (EYELA, N-1000, Japan) to prepare a Danshen root extract.
[실시예][Example]
실시예 1~3. 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 포함하는 화장료 조성물의 제조Examples 1-3. Preparation of Cosmetic Composition Containing Saffron Flower Extract and Danshen Root Extract
상기 제조예 2에서 제조한 샤프란 꽃 물 추출물 및 제조예 14에서 제조한 단삼 뿌리 추출물을 1:0.1, 1:0.5 및 1:1의 중량비로 혼합하여 화장료 조성물을 제조하였다. A cosmetic composition was prepared by mixing the saffron flower water extract prepared in Preparation Example 2 and the Danshen root extract prepared in Preparation Example 14 at weight ratios of 1:0.1, 1:0.5, and 1:1.
실시예 4. 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 포함하는 크림 제형 화장료 조성물의 제조Example 4. Preparation of a Creamy Cosmetic Composition Containing Saffron Flower Extract and Danshen Root Extract
하기 표 1의 성분 및 함량을 포함하는 크림 제형의 화장료 조성물을 제조하였다. 본 명세서에서 다른 언급이 없는 한 함량은 중량%이다. A cosmetic composition in a cream formulation containing the ingredients and contents of Table 1 below was prepared. In this specification, unless otherwise indicated, content is % by weight.
성분ingredient 함량content
정제수 Purified water 52.362552.3625
소듐파이테이트 sodium phytate 0.020.02
하이드록시아세토페논Hydroxyacetophenone 0.20.2
글리세린 glycerin 55
판테놀 panthenol 1One
펜틸렌글라이콜 pentylene glycol 22
1,2-헥산다이올 1,2-Hexanediol 1One
글리세린 glycerin 22
잔탄검 xanthan gum 0.070.07
트로메타민 tromethamine 0.150.15
소듐카보머 sodium carbomer 0.350.35
하이드록시에틸아크릴레이트/소듐아크릴로일다이메틸타우레이트코폴리머Hydroxyethyl Acrylate/Sodium Acryloyl Dimethyl Taurate Copolymer 0.04750.0475
폴리글리세릴-3메틸글루코오스다이스테아레이트 Polyglyceryl-3methylglucose distearate 22
폴리글리세릴-3다이스테아레이트Polyglyceryl-3-distearate 1.891.89
글리세릴스테아레이트시트레이트Glyceryl Stearate Citrate 0.110.11
카프릴릭/카프릭/미리스틱/스테아릭트라이글리세라이드 Caprylic/Capric/Myristic/Stearic Triglyceride 0.50.5
코코넛야자오일 coconut palm oil 22
스쿠알란 squalane 22
카프릴릭/카프릭트라이글리세라이드 Caprylic/Capric Triglyceride 44
정제수 Purified water 2020
아크릴레이트/C10-30알킬아크릴레이트크로스폴리머Acrylates/C10-30 Alkyl Acrylate Crosspolymer 0.20.2
정제수Purified water 2.942.94
제조예 2Preparation Example 2 0.030.03
1,2-헥산다이올 1,2-Hexanediol 0.0150.015
카프릴릴글라이콜 caprylyl glycol 0.0150.015
부틸렌글라이콜Butylene Glycol 0.0850.085
정제수Purified water 0.0120.012
제조예 14Preparation Example 14 0.0030.003
[비교예][Comparative example]
비교예 1. 크림 제형의 화장료 조성물의 제조Comparative Example 1. Preparation of a creamy cosmetic composition
하기 표 2의 성분 및 함량을 포함하였다는 점을 제외하고는 상기 실시예 4와 동일한 방법으로 크림 제형의 화장료 조성물을 제조하였다.A creamy cosmetic composition was prepared in the same manner as in Example 4, except that the components and contents of Table 2 were included.
성분ingredient 함량content
정제수 Purified water 55.462555.4625
소듐파이테이트 sodium phytate 0.020.02
하이드록시아세토페논Hydroxyacetophenone 0.20.2
글리세린 glycerin 55
판테놀 panthenol 1One
펜틸렌글라이콜 pentylene glycol 22
1,2-헥산다이올 1,2-Hexanediol 1One
글리세린 glycerin 22
잔탄검 xanthan gum 0.070.07
트로메타민 tromethamine 0.150.15
소듐카보머 sodium carbomer 0.350.35
하이드록시에틸아크릴레이트/소듐아크릴로일다이메틸타우레이트코폴리머Hydroxyethyl Acrylate/Sodium Acryloyl Dimethyl Taurate Copolymer 0.04750.0475
폴리글리세릴-3메틸글루코오스다이스테아레이트 Polyglyceryl-3methylglucose distearate 22
폴리글리세릴-3다이스테아레이트Polyglyceryl-3-distearate 1.891.89
글리세릴스테아레이트시트레이트Glyceryl Stearate Citrate 0.110.11
카프릴릭/카프릭/미리스틱/스테아릭트라이글리세라이드 Caprylic/Capric/Myristic/Stearic Triglyceride 0.50.5
코코넛야자오일 coconut palm oil 22
스쿠알란 squalane 22
카프릴릭/카프릭트라이글리세라이드 Caprylic/Capric Triglyceride 44
정제수 Purified water 2020
아크릴레이트/C10-30알킬아크릴레이트크로스폴리머Acrylates/C10-30 Alkyl Acrylate Crosspolymer 0.20.2
[실험예][Experimental Example]
실험예 1. 탈색 과정에 따른 샤프란 꽃 추출물의 색조 및 크로신 화합물 확인Experimental Example 1. Identification of color and crocin compounds of saffron flower extracts according to decolorization process
상기 제조예 1~13에서 제조한 샤프란 꽃 추출물의 탈색 과정에 따른 표면 색조를 육안으로 관찰하였다. 또한, 샤프란 꽃 추출물의 주요 성분에 해당하는 크로신 화합물의 함량을 HPTLC(High-Performance Thin Layer Chromatography)로 확인하여 표 3에 나타내었다. The surface color of the saffron flower extract prepared in Preparation Examples 1 to 13 according to the decolorization process was visually observed. In addition, the content of the crocin compound corresponding to the main component of the saffron flower extract was confirmed by HPTLC (High-Performance Thin Layer Chromatography) and shown in Table 3.
제조예 1Preparation Example 1 제조예 2Preparation Example 2 제조예 3Preparation Example 3 제조예 4Production Example 4 제조예 5Preparation Example 5 제조예 6Preparation Example 6 제조예 7Preparation Example 7 제조예 8Preparation Example 8 제조예 9Preparation Example 9 제조예 10Preparation Example 10 제조예 11Preparation Example 11 제조예 12Preparation Example 12 제조예 13Preparation Example 13
크로신 농도crocin concentration +/-+/- -- +/-+/- +/-+/- +/-+/- -- -- ++++++++ ++++ +/-+/- +/-+/- ++++ ++++++++
++++: 다량 검출됨++++: Large amount detected
++: 검출됨++: detected
+/-: 소량 검출됨+/-: small amount detected
-: 검출되지 않음-: not detected
도 1은 탈색 과정 유무에 따른 샤프란 꽃 추출물의 색을 나타낸 사진이다.1 is a photograph showing the color of a saffron flower extract with or without a decolorization process.
그 결과, 도 1에 나타낸 바와 같이, 탈색 과정을 포함하지 않는 제조예 9는 붉은 색을 띠었으나, 탈색 과정을 추가로 포함하는 제조예 2는 노란 색조를 나타내는 것을 확인할 수 있었다. As a result, as shown in FIG. 1, it was confirmed that Preparation Example 9, which did not include a bleaching process, had a red color, but Preparation Example 2, which additionally included a bleaching process, exhibited a yellow tint.
또한, 표 1에 나타낸 바와 같이, 탈색 과정이 포함되지 않은 경우, 크로신 화합물이 일정 농도 이상으로 검출되었으나 탈색 과정을 추가로 포함한 제조예 2, 6~7은 크로신 화합물이 검출되지 않았다. In addition, as shown in Table 1, when the bleaching process was not included, the crocin compound was detected at a certain concentration or higher, but in Preparation Examples 2 and 6-7, which further included a bleaching process, the crocin compound was not detected.
즉, 탈색에 의하여 샤프란의 색을 담당하는 화학 물질인 크로신 화합물이 제거된 것을 알 수 있다. That is, it can be seen that the crocin compound, which is a chemical substance responsible for the color of saffron, is removed by decolorization.
실험예 2. 크로신 화합물의 유무에 따른 항노화 및 항주름 활성 확인Experimental Example 2. Confirmation of anti-aging and anti-wrinkle activity according to the presence or absence of crocin compound
샤프란은 크로신(crocin), 피크로크로신(picrocrocin) 및 사프라날(safranal) 등과 같은 화합물을 주요 성분으로 포함하고 있다. 따라서, 주요 성분 중 하나인 크로신 화합물의 유무에 따라 항노화 및 항주름 활성의 차이가 발생하는지 여부를 확인하였다. 구체적으로, 인간 섬유아세포 세포주(Human dermal fibroblast, Hs68)를 37℃, 5% CO2 조건의 배양기에서 48시간 동안 배양하였다. 이후, Biosun UV 램프를 통해 UVA 10 J/cm2를 조사하거나 조사하지 않았다. UVA 조사 직후, 상기 제조예 2 및 제조예 9를 농도별(1.0% 및 2.0%)로 처리하고, 48시간 동안 추가 배양하였다. 이후, MMP-1 발현량을 ELISA로 측정하였다. 양성대조군으로는 크로신 화합물 10 ㎍/mL 또는 100 ㎍/mL을 사용하였다. Saffron contains compounds such as crocin, picrocrocin, and safranal as main components. Therefore, it was confirmed whether a difference in anti-aging and anti-wrinkle activity occurs depending on the presence or absence of the crocin compound, which is one of the main components. Specifically, a human dermal fibroblast cell line (Human dermal fibroblast, Hs68) was cultured for 48 hours in an incubator at 37°C and 5% CO 2 conditions. Then, UVA 10 J/cm 2 was irradiated or not irradiated through a Biosun UV lamp. Immediately after UVA irradiation, Preparation Example 2 and Preparation Example 9 were treated by concentration (1.0% and 2.0%), and further cultured for 48 hours. Then, the expression level of MMP-1 was measured by ELISA. As a positive control group, 10 μg/mL or 100 μg/mL of Crocin compound was used.
도 2는 크로신 화합물의 유무에 따른 샤프란 꽃 추출물이 MMP-1의 발현에 미치는 영향을 나타낸 그래프이다.Figure 2 is a graph showing the effect of saffron flower extracts on the expression of MMP-1 according to the presence or absence of a crocin compound.
그 결과, 도 2에 나타낸 바와 같이, 섬유아세포는 자외선의 조사에 의해 MMP-1의 발현이 증가하였고, 제조예 2 및 제조예 9를 처리함으로써 증가된 MMP-1의 발현이 감소하는 것을 확인할 수 있었다. As a result, as shown in Figure 2, it can be confirmed that the expression of MMP-1 was increased in the fibroblasts by irradiation of ultraviolet rays, and the increased expression of MMP-1 was reduced by treating Preparation Examples 2 and 9. there was.
실험예 3. 크로신 화합물의 유무에 따른 피부 탄력 개선 효과 확인Experimental Example 3. Confirmation of skin elasticity improvement effect according to the presence or absence of crocin compound
크로신 화합물의 유무에 따른 피부 탄력 개선 효과를 확인하였다. 구체적으로, 인간 섬유아세포 세포주(Human dermal fibroblast, Hs68)를 37℃, 5% CO2 조건의 배양기에서 48시간 동안 배양하였다. 이후, 상기 제조예 2 및 제조예 9를 농도별(1.0% 및 2.0%)로 처리하고, 24시간 동안 추가 배양하였다. 이후, 배양 상청액을 -80℃에서 보관한 뒤, 콜라겐 발현량을 ELISA로 측정하였다. 양성대조군으로는 크로신 화합물 10 ㎍/mL을 사용하였다. The effect of improving skin elasticity according to the presence or absence of the crocin compound was confirmed. Specifically, a human dermal fibroblast cell line (Human dermal fibroblast, Hs68) was cultured for 48 hours in an incubator at 37°C and 5% CO 2 conditions. Thereafter, Preparation Example 2 and Preparation Example 9 were treated by concentration (1.0% and 2.0%), and further cultured for 24 hours. Thereafter, the culture supernatant was stored at -80 ° C, and the amount of collagen expression was measured by ELISA. As a positive control group, 10 μg/mL of Crocin compound was used.
도 3은 크로신 화합물의 유무에 따른 샤프란 꽃 추출물이 콜라겐 생성에 미치는 영향을 나타낸 그래프이다.Figure 3 is a graph showing the effect of saffron flower extract on collagen production according to the presence or absence of a crocin compound.
그 결과, 도 3에 나타낸 바와 같이, 제조예 2 및 제조예 9는 농도 의존적으로 콜라겐의 발현을 증가시키는 것을 확인할 수 있었다. 특히, 탈색에 의하여 크로신 화합물이 제거된 제조예 2의 경우, 크로신 화합물을 포함하는 제조예 9에 비해 유의하게 콜라겐 발현을 증가시키는 것을 확인할 수 있었다. 따라서, 일 구체예에 따른 샤프란 꽃 추출물은 크로신 화합물의 유무에 관계 없이 피부 탄력 개선 효과를 나타낼 수 있다. As a result, as shown in Figure 3, Preparation Example 2 and Preparation Example 9 was confirmed to increase the expression of collagen in a concentration-dependent manner. In particular, in the case of Preparation Example 2 in which the Crocin compound was removed by decolorization, it was confirmed that collagen expression was significantly increased compared to Preparation Example 9 containing the Crocin compound. Therefore, the saffron flower extract according to one embodiment may exhibit an effect of improving skin elasticity regardless of the presence or absence of the crocin compound.
실험예 4. 크로신 화합물의 유무에 따른 피부 상처 치유 및 재생 효과 확인Experimental Example 4. Confirmation of skin wound healing and regeneration effects according to the presence or absence of crocin compound
크로신 화합물의 유무에 따른 피부 상처 치유 및 재생 효과를 확인하였다. 구체적으로, 인간 섬유아세포 세포주(Human dermal fibroblast, Hs68)를 37℃, 5% CO2 조건의 배양기에서 배양하여 100% 컨플루언시(cohfluency)한 상태로 만들었다. 이후, 파이펫 팁(pipette tip)을 사용하여 웰의 가운데를 가로지르도록 임의로 긁어 상처를 낸 후, 상기 제조예 2 및 제조예 9를 1.0%로 포함하는 배지로 각각 교체하여 24시간 동안 추가로 배양하였다. 이후, 전자현미경을 이용하여 섬유아세포의 세포 이동 모습을 관찰하였다. 양성대조군으로는 크로신 화합물 10 ㎍/mL을 사용하였다. Skin wound healing and regeneration effects according to the presence or absence of the Crocin compound were confirmed. Specifically, a human dermal fibroblast cell line (Hs68) was cultured in an incubator at 37° C. and 5% CO 2 to reach 100% confluency. Thereafter, using a pipette tip, randomly scrape across the center of the well to make a wound, and then replace the above Preparation Example 2 and Preparation Example 9 with a medium containing 1.0%, respectively, for an additional 24 hours. cultured. Then, cell migration of the fibroblasts was observed using an electron microscope. As a positive control group, 10 μg/mL of Crocin compound was used.
도 4는 크로신 화합물의 유무에 따른 샤프란 꽃 추출물이 상처 치유 및 피부 재생에 미치는 영향을 나타낸 결과이다. Figure 4 is a result showing the effect of saffron flower extract on wound healing and skin regeneration according to the presence or absence of a crocin compound.
그 결과, 도 4에 나타낸 바와 같이, 상처 유발에 의해 노화된 섬유화세포는 젊은 세포에 의해 세포 이동이 유의적으로 감소하였으며, 노화된 세포에 크로신 화합물, 제조예 2 및 제조예 9를 처리함으로써 세포 이동이 유의적으로 증가한 것을 확인할 수 있었다. 특히, 제조예 2의 경우, 노화된 세포에 비해 세포 이동이 38% 이상 증가하여 세포 이동이 8% 증가한 크로신 화합물 및 제조예 9에 비하여 현저한 세포 이동 효과를 나타내었다. As a result, as shown in Figure 4, fibrotic cells aged by wounding significantly reduced cell migration by young cells, and by treating senescent cells with the Crocin compound, Preparation Example 2 and Preparation Example 9 It was confirmed that cell migration was significantly increased. In particular, in the case of Preparation Example 2, cell migration was increased by 38% or more compared to senescent cells, showing a remarkable cell migration effect compared to the Crocin compound and Preparation Example 9, in which cell migration increased by 8%.
따라서, 일 구체예에 따른 샤프란 꽃 추출물은 크로신 화합물을 포함하지 않음에도 노화된 섬유아세포에서 세포 이동을 촉진함으로써 피부 상처를 치료할 수 있을 뿐만 아니라, 피부 재생 효과를 나타낼 수 있다. Therefore, the saffron flower extract according to one embodiment can not only treat skin wounds by promoting cell migration in aged fibroblasts, but also exhibit skin regeneration effects, even though it does not contain a crocin compound.
실험예 5. 항노화 및 항주름 시너지 활성 확인Experimental Example 5. Confirmation of anti-aging and anti-wrinkle synergistic activity
상기 실험예의 결과를 종합하여 볼 때, 샤프란 꽃 추출물은 크로신 화합물의 유무에 관계 없이 피부 상태 개선 효과를 가지는 것을 확인할 수 있다. 따라서, 이하에서는 샤프란 꽃 추출물과 단삼 뿌리 추출물의 혼합물이 각각의 단독 추출물과 비교하여 항노화 및 항주름의 시너지 활성을 가지는지 여부를 확인하였다. 구체적으로, 인간 섬유아세포 세포주(Human dermal fibroblast, Hs68)를 6 웰 플레이트에 3x105로 분주한 후, 37℃, 5% CO2 조건의 배양기에서 24시간 동안 배양하였다. 이후 배지를 제거하고 DPBS를 넣어준 후 20 mJ/cm2의 UVB를 조사하거나 조사하지 않고, 상기 실시예 1~3을 각각 1%의 농도로 첨가하여 24시간 동안 추가로 배양하였다. 이후, 각 시료의 세포에서 트리졸(RNA iso, DAKARA, 일본)을 이용하여 RNA를 분리한 뒤 nanodrop으로 260 ㎚에서 RNA를 정량한 후, 각각 2㎍의 RNA를 사용하여 증폭기에서 cDNA를 합성하였다(C1000 Thermal Cycler, Bio-Rad, 미국). 합성된 cDNA를 주형으로 타겟 유전자인 MMP-1(Matrix metalloproteinase-1) 및 COL1A1에 대하여 사이버그린 (SYBR Green supermix, Applied Biosystems, USA)을 프라이머 및 cDNA와 함께 첨가하여 실시간(real-time) PCR 기계 (Step One Plus, Applied Biosystems, 미국)에서 실시간 중합효소 연쇄반응을 수행하였다. 유전자의 발현량은 β-actin 유전자에 대한 보정을 통해 최종적으로 분석하였다. 양성대조군으로 EGCG 1 μM을 사용하였다. In view of the results of the above experimental examples, it can be confirmed that the saffron flower extract has a skin condition improvement effect regardless of the presence or absence of the crocin compound. Therefore, in the following, it was confirmed whether the mixture of the saffron flower extract and the Danshen root extract has synergistic activity of anti-aging and anti-wrinkle compared to each single extract. Specifically, human dermal fibroblast cell line (Human dermal fibroblast, Hs68) was divided into 3x10 5 in a 6-well plate, and then cultured for 24 hours in an incubator at 37°C and 5% CO 2 conditions. Thereafter, the medium was removed, DPBS was added, and 20 mJ/cm 2 of UVB was irradiated or not irradiated, and Examples 1 to 3 were added at a concentration of 1%, respectively, and further cultured for 24 hours. Thereafter, RNA was isolated from the cells of each sample using Trizol (RNA iso, DAKARA, Japan), RNA was quantified at 260 nm with nanodrop, and cDNA was synthesized in an amplifier using 2 μg of RNA. (C1000 Thermal Cycler, Bio-Rad, USA). Using the synthesized cDNA as a template, cybergreen (SYBR Green supermix, Applied Biosystems, USA) was added together with primers and cDNA for the target genes MMP-1 (Matrix metalloproteinase-1) and COL1A1, and real-time PCR machine (Step One Plus, Applied Biosystems, USA) real-time polymerase chain reaction was performed. The expression level of the gene was finally analyzed through correction for the β-actin gene. EGCG 1 μM was used as a positive control.
도 5는 일 구체예에 따른 화장료 조성물이 MMP-1의 발현에 미치는 영향을 나타낸 그래프이다. Figure 5 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of MMP-1.
도 6은 일 구체예에 따른 화장료 조성물이 COL1A1의 발현에 미치는 영향을 나타낸 그래프이다.Figure 6 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of COL1A1.
그 결과, 도 5에 나타낸 바와 같이, 섬유아세포는 자외선의 조사에 의해 MMP-1의 발현이 증가하였고, 실시예 1~3을 처리함으로써 증가된 MMP-1의 발현이 감소하는 것을 확인할 수 있었다. 구체적으로, 실시예 1~3은 샤프란 꽃 추출물 단독 처리한 경우와 비교하여 MMP-1의 발현을 현저하게 감소시키는 것을 확인할 수 있었다. 또한, 도 6에 나타낸 바와 같이, 실시예 1~3은 제조예 2 및 제조예 14에 비하여 COL1A1 발현을 현저하게 증가시키는 것을 확인할 수 있었다. As a result, as shown in FIG. 5, it was confirmed that the expression of MMP-1 was increased in the fibroblasts by UV irradiation, and the increased expression of MMP-1 was decreased by treating Examples 1 to 3. Specifically, it was confirmed that Examples 1 to 3 significantly reduced the expression of MMP-1 compared to the case of treatment with the saffron flower extract alone. In addition, as shown in FIG. 6, it was confirmed that Examples 1 to 3 significantly increased COL1A1 expression compared to Preparation Examples 2 and 14.
즉, 일 양상에 따른 화장료 조성물은 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 포함함으로써 자외선에 의해 증가된 MMP-1의 발현을 감소시키고, COL1A1의 발현을 증가시키는 바, 우수한 항노화 및 항주름 활성을 가질 수 있다.That is, the cosmetic composition according to one aspect reduces the expression of MMP-1 increased by ultraviolet rays and increases the expression of COL1A1 by including a saffron flower extract and a Danshen root extract, thereby having excellent anti-aging and anti-wrinkle activity. can
실험예 6. 피부 탄력 개선의 시너지 효과 확인Experimental Example 6. Confirmation of synergistic effect of improving skin elasticity
샤프란 꽃 추출물과 단삼 뿌리 추출물의 혼합물이 각각의 단독 추출물과 비교하여 피부 탄력 개선의 시너지 활성을 가지는지 여부를 확인하였다. 구체적으로, 인간 섬유아세포 세포주(Human dermal fibroblast, Hs68)를 6 웰 플레이트에 4X105의 밀도로 접종한 후 37℃, 5% CO2 배양기에서 24시간 배양하였다. 이후, PBS로 세척한 뒤, FBS를 포함하지 않는 DMEM 배지에 상기 실시예 1~3을 각각 1% 농도로 처리하여 24시간 동안 추가로 배양하였다. 이후, COL1A1, 엘라스틴(ELN) 및 피브릴린(FBN)에 대한 프라이머를 사용하였다는 점을 제외하고는 상기와 동일한 방법으로 COL1A1, 엘라스틴(ELN) 및 피브릴린(FBN)의 유전자 발현량을 분석하였다. It was confirmed whether the mixture of the saffron flower extract and the Danshen root extract had a synergistic activity of improving skin elasticity compared to each single extract. Specifically, the human dermal fibroblast cell line (Human dermal fibroblast, Hs68) was inoculated in a 6-well plate at a density of 4X10 5 and then cultured at 37°C, 5% CO 2 incubator for 24 hours. Thereafter, after washing with PBS, each of Examples 1 to 3 was treated at a concentration of 1% in DMEM medium without FBS, and further cultured for 24 hours. Thereafter, the gene expression levels of COL1A1, elastin (ELN), and fibrillin (FBN) were measured in the same manner as above, except that primers for COL1A1, elastin (ELN), and fibrillin (FBN) were used. analyzed.
도 7은 일 구체예에 따른 화장료 조성물이 엘라스틴의 생성에 미치는 영향을 나타낸 그래프이다. 7 is a graph showing the effect of the cosmetic composition according to one embodiment on the production of elastin.
도 8은 일 구체예에 따른 화장료 조성물이 피브릴린의 발현에 미치는 영향을 나타낸 그래프이다.8 is a graph showing the effect of the cosmetic composition according to one embodiment on the expression of fibrillin.
그 결과, 도 7 및 도 8에 나타낸 바와 같이, 실시예 1~3은 제조예 2 및 제조예 14에 비하여 엘라스틴 및 피브릴린의 발현을 현저하게 증가시키는 것을 확인할 수 있었다. As a result, as shown in FIGS. 7 and 8 , it was confirmed that Examples 1 to 3 significantly increased the expression of elastin and fibrillin compared to Preparation Examples 2 and 14.
즉, 일 양상에 따른 화장료 조성물은 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 포함함으로써 각각의 단독 추출물에 비해 엘라스틴 및 피브릴린 발현이 현저하게 증가하는 바, 피부 탄력 개선의 시너지 효과를 나타낼 수 있다. That is, since the cosmetic composition according to one aspect includes a saffron flower extract and a Danshen root extract, the expression of elastin and fibrillin is significantly increased compared to each single extract, and thus, a synergistic effect of improving skin elasticity can be exhibited.
실험예 7. 피부 상처 치유 및 재생 시너지 효과 확인Experimental Example 7. Confirmation of skin wound healing and regeneration synergistic effect
샤프란 꽃 추출물과 단삼 뿌리 추출물의 혼합물이 각각의 단독 추출물과 비교하여 피부 상처 치유 및 재생의 시너지 활성을 가지는지 여부를 확인하였다. 구체적으로, 인간 섬유아세포 세포주(Human dermal fibroblast, Hs68)를 5x105 세포/웰의 농도로 6 웰 플레이트에 분주한 후, 37℃, 5% CO2 조건의 배양기에서 24 시간 동안 배양하여 100% 컨플루언시(confluency)한 상태로 만들었다. 이후, 파이펫 팁(pipette tip)을 사용하여 웰의 가운데를 가로지르도록 임의로 긁어 상처를 낸 후, 상기 실시예 1~3을 1.0%로 포함하는 배지로 각각 교체하여 24시간 동안 추가로 배양하였다. 이후, 전자현미경을 이용하여 섬유아세포의 세포 이동 모습을 관찰하였다. 양성대조군으로는 bEGF 10 ng/㎖를 사용하였다. It was confirmed whether the mixture of the saffron flower extract and the Danshen root extract had a synergistic activity of skin wound healing and regeneration compared to each single extract. Specifically, the human dermal fibroblast cell line (Human dermal fibroblast, Hs68) was dispensed into a 6-well plate at a concentration of 5x10 5 cells/well, and then cultured for 24 hours in an incubator at 37°C and 5% CO 2 conditions to achieve 100% confluency. It was made into a state of confluency. Thereafter, after arbitrarily scratching the center of the well using a pipette tip, the medium was replaced with a medium containing 1.0% of Examples 1 to 3, respectively, and further cultured for 24 hours. . Then, cell migration of the fibroblasts was observed using an electron microscope. As a positive control group, bEGF 10 ng/ml was used.
도 9A 및 도 9B는 일 구체예에 따른 화장료 조성물의 피부 재생 촉진 효과를 나타낸 결과이다. 9A and 9B are results showing the skin regeneration promoting effect of the cosmetic composition according to one embodiment.
그 결과, 도 9A 및 도 9B에 나타낸 바와 같이, 실시예 1~3은 제조예 14와 비교하여 상처가 유발된 섬유아세포의 회복에 현저한 효과를 나타내는 것을 확인할 수 있었다. As a result, as shown in FIGS. 9A and 9B, it was confirmed that Examples 1 to 3 showed a remarkable effect on the recovery of scarred fibroblasts compared to Preparation Example 14.
즉, 일 양상에 따른 화장료 조성물은 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 포함함으로써 상처 치유 및 피부 재생에 탁월한 효과를 가질 수 있다. That is, the cosmetic composition according to one aspect may have excellent effects on wound healing and skin regeneration by including the saffron flower extract and the Danshen root extract.
실험예 8. 피부 보습 및 주름개선 효과 확인Experimental Example 8. Confirmation of skin moisturizing and wrinkle improvement effects
샤프란 꽃 추출물과 단삼 뿌리 추출물의 혼합물이 피부 보습 및 주름 개선의 효과를 가지는지 여부를 확인하였다. 구체적으로, 피험자 5명(평균 나이 45세)에게 얼굴 안면부 좌/우에 실시예 4 및 비교예 1을 하루 2회씩 4주 동안 사용하게 하였다. 이후, 시험 부위를 비누로 세안하고 10분 간 항온항습실(22±2℃, 40~60% RH)에서 대기한 뒤, 피부 수분도(0주)를 측정하고 피부 주름(0주)을 촬영하였다. 제품 사용 2주 및 4주 후, 동일한 방법으로 피부 수분도 및 피부 주름을 측정하였으며 각 주차 3회 측정값의 평균을 산출하여 0주차 측정값과 비교하였다. It was confirmed whether the mixture of the saffron flower extract and the Danshen root extract had effects of moisturizing skin and improving wrinkles. Specifically, 5 subjects (average age 45 years old) were asked to use Example 4 and Comparative Example 1 twice a day for 4 weeks on the left/right side of the face. Then, the test site was washed with soap and waited in a constant temperature and humidity room (22 ± 2 ℃, 40 ~ 60% RH) for 10 minutes, and then the skin moisture level (0 weeks) was measured and skin wrinkles (0 weeks) were photographed. . After 2 weeks and 4 weeks of product use, skin moisture level and skin wrinkles were measured in the same way, and the average of the three measured values in each week was calculated and compared with the measured values in the 0th week.
도 10A 및 도 10B는 일 구체예에 따른 화장료 조성물의 피부 보습 효과를 나타낸 그래프이다. 10A and 10B are graphs showing the skin moisturizing effect of the cosmetic composition according to one embodiment.
도 11A, 도 11B 및 도 11C는 일 구체예에 따른 화장료 조성물의 피부 주름 개선 효과를 나타낸 결과이다.11A, 11B and 11C are results showing the skin wrinkle improvement effect of the cosmetic composition according to one embodiment.
그 결과, 도 10A 및 도 10B에 나타낸 바와 같이, 사용 4주후의 피부 수분도는 실시예 4 및 비교예 1이 각각 24.3% 및 5.0%를 나타내어 사용 전과 비교하여 증가한 것을 확인할 수 있었다. 특히, 실시예 4는 비교예 1과 비교하여 피부 수분도가 현저하게 증가한 것을 확인할 수 있었다. As a result, as shown in FIGS. 10A and 10B, it was confirmed that the skin moisture level after 4 weeks of use was 24.3% and 5.0% in Example 4 and Comparative Example 1, respectively, and increased compared to before use. In particular, in Example 4, it was confirmed that the skin moisture level was significantly increased compared to Comparative Example 1.
또한, 도 11A 내지 도 11C에 나타낸 바와 같이, 실시예 4 및 비교예 1는 사용 시간이 증가함에 따라 피부 침하도(indentation)이 감소한 것을 확인할 수 있었다. 특히, 실시예 4는 비교예 1과 비교하여 사용 4주차의 피부 침하도 증감율이 유의적으로 감소한 것을 확인할 수 있었다. In addition, as shown in FIGS. 11A to 11C, it was confirmed that Example 4 and Comparative Example 1 decreased skin indentation as the use time increased. In particular, in Example 4, it was confirmed that the rate of change in skin subsidence at the 4th week of use was significantly reduced compared to Comparative Example 1.
즉, 일 양상에 따른 화장료 조성물은 피부 보습 및 주름 개선에 탁월한 효과가 있다. That is, the cosmetic composition according to one aspect has an excellent effect on skin moisturizing and wrinkle improvement.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.The above description of the present invention is for illustrative purposes, and those skilled in the art can understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, the embodiments described above should be understood as illustrative in all respects and not limiting.

Claims (8)

  1. 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 유효성분으로 포함하는 피부 상태 개선용 화장료 조성물.A cosmetic composition for improving skin condition comprising saffron flower extract and Danshen root extract as active ingredients.
  2. 청구항 1에 있어서, 상기 샤프란 꽃 추출물은 물, C1 내지 C4의 저급 알코올 또는 이들의 혼합물을 용매로 추출한 것인 화장료 조성물.The cosmetic composition according to claim 1, wherein the saffron flower extract is obtained by extracting water, C1 to C4 lower alcohol, or a mixture thereof using a solvent.
  3. 청구항 1에 있어서, 상기 샤프란 꽃 추출물은 물 및 탄수화물 분해효소(carbonhydrase)의 혼합물을 용매로 추출하는 단계; 및 The method according to claim 1, wherein the saffron flower extract is extracted with a mixture of water and carbohydrate decomposition enzyme (carbonhydrase) as a solvent; and
    상기 샤프란 꽃 추출물을 탈색하는 단계를 포함하여 추출한 것인 화장료 조성물.A cosmetic composition obtained by decolorizing the saffron flower extract.
  4. 청구항 1에 있어서, 상기 단삼 뿌리 추출물은 물, C1 내지 C4의 저급 알코올 또는 이들의 혼합물을 용매로 추출한 것인 화장료 조성물.The cosmetic composition according to claim 1, wherein the Danshen root extract is obtained by extracting water, C1 to C4 lower alcohol, or a mixture thereof with a solvent.
  5. 청구항 1에 있어서, 상기 피부 상태 개선은 피부 노화, 피부 장벽 강화, 상처 치료, 피부 주름, 피부 탄력 또는 보습인 것인 화장료 조성물.The cosmetic composition according to claim 1, wherein the skin condition improvement is skin aging, skin barrier strengthening, wound healing, skin wrinkles, skin elasticity or moisturizing.
  6. 청구항 1에 있어서, 상기 샤프란 꽃 추출물 및 단삼 뿌리 추출물은 1:0.01 내지 1:10의 중량비로 혼합된 것인 화장료 조성물.The cosmetic composition according to claim 1, wherein the saffron flower extract and the Danshen root extract are mixed in a weight ratio of 1:0.01 to 1:10.
  7. 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 유효성분으로 포함하는 피부 상태 개선용 피부외용제용 조성물.A composition for external application for skin for improving skin conditions, comprising a saffron flower extract and a Danshen root extract as active ingredients.
  8. 샤프란 꽃 추출물 및 단삼 뿌리 추출물을 유효성분으로 포함하는 피부 상태 개선용 건강기능식품 조성물.A health functional food composition for improving skin conditions comprising saffron flower extract and Danshen root extract as active ingredients.
PCT/KR2023/001653 2022-02-07 2023-02-06 Cosmetic composition comprising saffron flower extract and danshen extract WO2023149766A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2022-0015771 2022-02-07
KR1020220015771A KR20230119520A (en) 2022-02-07 2022-02-07 Cosmetic composition comprising extractions of Crocus sativus flower and Salvia miltiorrhiza

Publications (1)

Publication Number Publication Date
WO2023149766A1 true WO2023149766A1 (en) 2023-08-10

Family

ID=87552698

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2023/001653 WO2023149766A1 (en) 2022-02-07 2023-02-06 Cosmetic composition comprising saffron flower extract and danshen extract

Country Status (2)

Country Link
KR (1) KR20230119520A (en)
WO (1) WO2023149766A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361516A (en) * 2008-09-18 2009-02-11 赵人洁 Traditional Chinese medicine cosmetic health-care tea
KR101742866B1 (en) * 2015-04-10 2017-06-15 서인경 Cosmetic composition for improving skin elasticity and winkles
CN110538099A (en) * 2018-05-29 2019-12-06 范丽荣 Plant-refined, condensed, moisturizing, firming, skin-refreshing and beautifying facial mask
CN110859792A (en) * 2019-11-11 2020-03-06 李利 Mask with cell repairing effect and preparation method thereof
CN112587657A (en) * 2020-12-29 2021-04-02 山东丽达生物科技集团有限公司 Traditional Chinese medicine biological preparation for promoting skin health, moistening and tendering red skin and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361516A (en) * 2008-09-18 2009-02-11 赵人洁 Traditional Chinese medicine cosmetic health-care tea
KR101742866B1 (en) * 2015-04-10 2017-06-15 서인경 Cosmetic composition for improving skin elasticity and winkles
CN110538099A (en) * 2018-05-29 2019-12-06 范丽荣 Plant-refined, condensed, moisturizing, firming, skin-refreshing and beautifying facial mask
CN110859792A (en) * 2019-11-11 2020-03-06 李利 Mask with cell repairing effect and preparation method thereof
CN112587657A (en) * 2020-12-29 2021-04-02 山东丽达生物科技集团有限公司 Traditional Chinese medicine biological preparation for promoting skin health, moistening and tendering red skin and preparation method thereof

Also Published As

Publication number Publication date
KR20230119520A (en) 2023-08-16

Similar Documents

Publication Publication Date Title
WO2020060060A1 (en) Cosmetic composition comprising centella asiatica adventitious root extract as effective ingredient for skin whitening and wrinkle reduction
WO2018174453A1 (en) Composition containing cirsium japonicum extract as active ingredient for stimulating melanogenesis
WO2019066121A1 (en) Composition comprising plant-derived extracellular vesicles
WO2023177188A1 (en) Cosmetic composition having anti-inflammatory and barrier effects, comprising fresh centella asiatica extract obtained through diffusion-based sugar extraction, and use thereof
WO2019143055A1 (en) Composition, comprising extract of fermented beans obtained from fermentation by aspergillus fumigatus strain, for skin care improvement
WO2023149766A1 (en) Cosmetic composition comprising saffron flower extract and danshen extract
KR102176883B1 (en) Composition for skin regeneration, anti-wrinkle, or wound healing containing Prunus persica resin
KR102321536B1 (en) Corynebacterium amycolatum strain and skin condition improving uses of thereof
KR102334454B1 (en) Corynebacterium tuberculostearicum strain and skin condition improving uses of thereof
KR102334455B1 (en) Corynebacterium macginleyi strain and skin condition improving uses of thereof
KR102586125B1 (en) Antioxidant, anti-inflammatory and skin anti-aging composition comprising nano-liposome containing complex plant extracts as active ingredients
WO2020111540A1 (en) Pharmaceutical composition for preventing or treating aging or aging-related diseases comprising anthocyanin-polysaccharide complex as active ingredient
WO2023224274A1 (en) Cosmetic composition comprising supercritical extract of fusidium coccineum strain cells
KR102484422B1 (en) Cosmetic composition comprising extract of Cactus and fermented product of Lactobacillus
WO2022114784A1 (en) Composition comprising fermentation product of cactus oil and use thereof for improving skin condition
KR102578892B1 (en) Cosmetic composition comprising a fermented product obtained by fermenting a plant extract using a Bacillus stain
WO2023090708A1 (en) Composition comprising oat grain syrup or extract therefrom for skin moisturization, wrinkle reduction, and antioxidation
KR20200142376A (en) Composition for whitening, anti-wrinkle or moisturizing comprising Cocos nucifera extract
KR102515074B1 (en) Cosmetic composition comprising fermented producrt of Perilla frutescens
WO2022114783A1 (en) Composition containing fermented product of cactus honey and use thereof for improving skin condition
KR102394429B1 (en) Composition comprising fermented snowberry and its use for improving skin condition
KR102334457B1 (en) Microbacterium oleivorans strain and skin condition improving uses of thereof
WO2023018077A1 (en) Microccocus cohnii strain, and use thereof for improving condition of skin
WO2024025173A1 (en) Cosmetic composition comprising staphylococcus sp. strain, streptococcus sp. strain, cutibacterium sp. strain, enhydrobacter sp. strain, and dna fragment mixture
WO2022145960A9 (en) Weissella cibaria strain and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23749999

Country of ref document: EP

Kind code of ref document: A1